Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	structural constituent of postsynaptic actin cytoskeleton	ACTB ACTG1 POTEKP POTEE POTEF POTEI	9.51e-09	11	337	6	GO:0098973
GeneOntologyMolecularFunction	structural constituent of postsynapse	DLGAP1 ACTB ACTG1 POTEKP POTEE POTEF POTEI	8.58e-07	32	337	7	GO:0099186
GeneOntologyMolecularFunction	structural constituent of synapse	DLGAP1 ACTB ACTG1 POTEKP POTEE POTEF POTEI	5.95e-06	42	337	7	GO:0098918
GeneOntologyMolecularFunction	beta-catenin binding	SETD1A APC2 MET MED12 HDAC6 CDH3 CDH4 CDH6 CDH15 CDH17	3.69e-05	120	337	10	GO:0008013
GeneOntologyMolecularFunction	calcium, potassium:sodium antiporter activity	SLC24A5 SLC24A4 SLC24A2	4.65e-05	5	337	3	GO:0008273
GeneOntologyMolecularFunction	structural constituent of cytoskeleton	SPTA1 ACTB ACTG1 POTEKP POTEE TLN2 SYNM POTEF TLN1 POTEI	7.30e-05	130	337	10	GO:0005200
GeneOntologyMolecularFunction	calcium ion binding	CAPN14 SYT12 SPTA1 FSTL5 PKDREJ LRP1B RYR1 RYR3 FAT1 FAT2 HEG1 MAN1A2 ACAN PLCG1 COMP DSG2 FAT3 PCDHB12 PCDHB3 HMCN1 LRP2 MACF1 ATP2A2 CDH3 CDH4 CDH6 CDH15 CDH17	7.74e-05	749	337	28	GO:0005509
GeneOntologyMolecularFunction	extracellularly glycine-gated ion channel activity	GLRA1 GLRB GLRA3	9.18e-05	6	337	3	GO:0016933
GeneOntologyMolecularFunction	extracellularly glycine-gated chloride channel activity	GLRA1 GLRB GLRA3	9.18e-05	6	337	3	GO:0016934
GeneOntologyMolecularFunction	nuclear vitamin D receptor binding	MED24 MED12 MED13 MED1	2.02e-04	18	337	4	GO:0042809
GeneOntologyMolecularFunction	nuclear thyroid hormone receptor binding	MED24 BRD8 MED12 MED13 MED1	2.47e-04	34	337	5	GO:0046966
GeneOntologyMolecularFunction	inhibitory extracellular ligand-gated monoatomic ion channel activity	GLRA1 GLRB GLRA3	2.51e-04	8	337	3	GO:0005237
GeneOntologyMolecularFunction	calcium ion transmembrane transporter activity	SLC24A5 PKDREJ RYR1 RYR3 SLC24A4 SLC24A2 CNGA3 TMC2 ATP2A2 ATP2A3	2.51e-04	151	337	10	GO:0015085
GeneOntologyMolecularFunction	N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity	AGA ASRGL1	2.84e-04	2	337	2	GO:0003948
GeneOntologyMolecularFunction	calcium:sodium antiporter activity	SLC24A5 SLC24A4 SLC24A2	5.24e-04	10	337	3	GO:0005432
GeneOntologyMolecularFunction	nuclear receptor coactivator activity	MED24 BRD8 MED12 MED13 MED1 TMF1	5.62e-04	61	337	6	GO:0030374
GeneOntologyMolecularFunction	protein tyrosine kinase activity	ERBB4 JAK2 MET TTBK1 ROR1 PEAK1 MAP2K1 MAP2K2 EPHB1	8.12e-04	145	337	9	GO:0004713
GeneOntologyMolecularFunction	calcium:monoatomic cation antiporter activity	SLC24A5 SLC24A4 SLC24A2	1.20e-03	13	337	3	GO:0015368
GeneOntologyMolecularFunction	vinculin binding	RTCB SYNM TLN1	1.20e-03	13	337	3	GO:0017166
GeneOntologyMolecularFunction	cell adhesion molecule binding	ITGA4 PAK6 DSCAML1 TLN2 CNGA3 VWF COMP DSG2 TNC ADAMTS5 ISG15 TLN1 MACF1 FSCN1 PCBP1 CDH3 CDH4 CDH6 CDH15 CDH17 TJP3	1.36e-03	599	337	21	GO:0050839
GeneOntologyMolecularFunction	extracellular matrix structural constituent	RELN MEPE ACAN COL14A1 COL6A3 VWF COMP TNC HMCN1 MUC6	1.39e-03	188	337	10	GO:0005201
GeneOntologyMolecularFunction	retinoic acid 4-hydroxylase activity	CYP2C18 CYP3A5 CYP3A43	1.51e-03	14	337	3	GO:0008401
GeneOntologyMolecularFunction	glycine binding	GLRA1 GLRB GLRA3	1.51e-03	14	337	3	GO:0016594
GeneOntologyMolecularFunction	calcium channel activity	SLC24A5 PKDREJ RYR1 RYR3 SLC24A4 SLC24A2 CNGA3 TMC2	1.58e-03	129	337	8	GO:0005262
GeneOntologyMolecularFunction	nucleobase:monoatomic cation symporter activity	SLC28A2 SLC28A1	1.67e-03	4	337	2	GO:0015391
GeneOntologyMolecularFunction	pyrimidine- and adenosine-specific:sodium symporter activity	SLC28A2 SLC28A1	1.67e-03	4	337	2	GO:0015389
GeneOntologyMolecularFunction	testosterone 16-alpha-hydroxylase activity	CYP3A5 CYP3A43	1.67e-03	4	337	2	GO:0008390
GeneOntologyMolecularFunction	nucleoside:sodium symporter activity	SLC28A2 SLC28A1	1.67e-03	4	337	2	GO:0005415
GeneOntologyMolecularFunction	ryanodine-sensitive calcium-release channel activity	RYR1 RYR3	1.67e-03	4	337	2	GO:0005219
GeneOntologyBiologicalProcess	cell junction organization	RELN ERBB4 ACTB ACTG1 POTEKP CSMD2 SORT1 POTEE HEG1 PTPN13 GLRB PKHD1 TLN2 ADGRF1 SDK1 SDC4 PICK1 HDAC6 DSG2 VEZT TNC POTEF PCDHB3 PTPN23 NBEA SLC6A1 TLN1 CNTNAP2 MACF1 APPL1 PEAK1 POTEI FSCN1 CDH3 CDH4 CDH6 CDH15 CDH17 TJP3 EPHB1	7.78e-08	974	336	40	GO:0034330
GeneOntologyBiologicalProcess	cell morphogenesis	RELN SPTA1 ACTB ACTG1 SPART POTEKP ITGA4 PAK6 DSCAML1 POTEE MET FAT1 HEG1 NBEAL2 PKHD1 PLXNA1 SEMA6C NPR2 WDR36 HDAC6 POTEF FAT3 FRYL MED1 AP3B1 ATL1 ZNF335 TET1 NR2E1 CNTNAP2 LRP2 MACF1 ELAVL4 ANKRD24 POTEI MAP2K1 MAP2K2 CDH3 CDH4 CDH6 CDH15 CDH17 PROX1 EPHB1	3.52e-07	1194	336	44	GO:0000902
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	DSCAML1 FAT1 FAT2 SDK1 DSG2 FAT3 PCDHB12 PCDHB3 PTPN23 HMCN1 CDH3 CDH4 CDH6 CDH15 CDH17	4.54e-07	187	336	15	GO:0007156
GeneOntologyBiologicalProcess	cell-cell junction organization	ACTB ACTG1 HEG1 PKHD1 TLN2 DSG2 PTPN23 TLN1 CNTNAP2 FSCN1 CDH3 CDH4 CDH6 CDH15 CDH17 TJP3	3.06e-06	246	336	16	GO:0045216
GeneOntologyBiologicalProcess	chordate embryonic development	TRAF6 MAN2A1 ITGA4 LRP1B DSCAML1 ITPK1 KPNA7 HEG1 BRCA2 SUPT6H BTF3 CC2D2A PLCG1 MED12 SDC4 FOXC1 RTCB VEZT SLC34A2 AMBRA1 CHD7 RUNX2 MED1 PALB2 PPP4R4 KMT2D SF3B1 ZNF335 TET1 CNTNAP2 LRP2 MAP2K1 PCNT PROX1	5.71e-06	906	336	34	GO:0043009
GeneOntologyBiologicalProcess	cell-cell adhesion	TRAF6 PDE4D NEXMIF HLA-DQB2 SPTA1 ACTB ACTG1 ITGA4 DSCAML1 JAK2 FAT1 FAT2 PKHD1 COL14A1 TLN2 SDK1 SDC4 CDON MIA3 COMP DSG2 VEZT FAT3 PCDHB12 PCDHB3 AMBRA1 PTPN23 AP3B1 CD160 HMCN1 TLN1 MAP2K1 CDH3 CDH4 CDH6 CDH15 CDH17 TJP3	6.54e-06	1077	336	38	GO:0098609
GeneOntologyBiologicalProcess	postsynaptic actin cytoskeleton organization	ACTB ACTG1 POTEKP POTEE POTEF POTEI	9.33e-06	31	336	6	GO:0098974
GeneOntologyBiologicalProcess	embryo development ending in birth or egg hatching	TRAF6 MAN2A1 ITGA4 LRP1B DSCAML1 ITPK1 KPNA7 HEG1 BRCA2 SUPT6H BTF3 CC2D2A PLCG1 MED12 SDC4 FOXC1 RTCB VEZT SLC34A2 AMBRA1 CHD7 RUNX2 MED1 PALB2 PPP4R4 KMT2D SF3B1 ZNF335 TET1 CNTNAP2 LRP2 MAP2K1 PCNT PROX1	9.69e-06	929	336	34	GO:0009792
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	RELN ACTB ACTG1 SPART POTEKP ITGA4 DSCAML1 POTEE MET PLXNA1 SEMA6C NPR2 WDR36 HDAC6 POTEF FAT3 ATL1 TET1 NR2E1 CNTNAP2 LRP2 MACF1 ELAVL4 ANKRD24 POTEI MAP2K1 MAP2K2 CDH4 EPHB1	1.58e-05	748	336	29	GO:0048667
GeneOntologyBiologicalProcess	postsynaptic cytoskeleton organization	ACTB ACTG1 POTEKP POTEE POTEF POTEI	1.95e-05	35	336	6	GO:0099188
GeneOntologyBiologicalProcess	axon development	RELN ACTB ACTG1 SPART POTEKP ITGA4 DSCAML1 JAK2 POTEE PLXNA1 SEMA6C NPR2 WDR36 HDAC6 TNC POTEF ATL1 NR2E1 CNTNAP2 LRP2 MACF1 POTEI MAP2K1 MAP2K2 CDH4 EPHB1	2.10e-05	642	336	26	GO:0061564
GeneOntologyBiologicalProcess	axonogenesis	RELN ACTB ACTG1 SPART POTEKP ITGA4 DSCAML1 POTEE PLXNA1 SEMA6C NPR2 WDR36 HDAC6 POTEF ATL1 NR2E1 CNTNAP2 LRP2 MACF1 POTEI MAP2K1 MAP2K2 CDH4 EPHB1	2.11e-05	566	336	24	GO:0007409
GeneOntologyBiologicalProcess	xenobiotic catabolic process	ACAA1 CYP3A5 UGT2B4 UGT2B7 UGT2B10 CYP3A43	2.71e-05	37	336	6	GO:0042178
GeneOntologyBiologicalProcess	protein localization to cell junction	DLGAP1 RELN ERBB4 TRAF6 ACTB ACTG1 HEG1 STX4 NBEA MAP2K1 TJP3	3.20e-05	148	336	11	GO:1902414
GeneOntologyBiologicalProcess	ventricular cardiac muscle tissue development	HEG1 COL14A1 FOXC1 DSG2 CHD7 MED1 LRP2 PROX1	3.28e-05	76	336	8	GO:0003229
GeneOntologyBiologicalProcess	anatomical structure homeostasis	TRAF6 ACTB ACTG1 TNFRSF11A BDKRB2 COL14A1 FOXC1 WDR36 COMP LRRK1 TEX15 EPG5 SLC28A2 CDH3 BBS12 MUC6 TJP3	3.76e-05	334	336	17	GO:0060249
GeneOntologyBiologicalProcess	tissue homeostasis	TRAF6 ACTB ACTG1 TNFRSF11A BDKRB2 COL14A1 FOXC1 WDR36 COMP LRRK1 TEX15 EPG5 SLC28A2 CDH3 BBS12 MUC6 TJP3	3.76e-05	334	336	17	GO:0001894
GeneOntologyBiologicalProcess	regulation of neurogenesis	RELN MAN2A1 SPART MET TTBK1 ACAN PLXNA1 CDON SEMA6C CYSLTR2 HDAC6 CHD7 NR1D1 FXR1 ZNF335 NR2E1 LRP2 MACF1 MAP2K1 MAP2K2 CDH4 PROX1	4.18e-05	515	336	22	GO:0050767
GeneOntologyBiologicalProcess	in utero embryonic development	TRAF6 MAN2A1 ITGA4 LRP1B KPNA7 HEG1 BRCA2 SUPT6H BTF3 PLCG1 FOXC1 RTCB SLC34A2 CHD7 MED1 PALB2 PPP4R4 KMT2D SF3B1 ZNF335 TET1 CNTNAP2 MAP2K1 PCNT	4.80e-05	596	336	24	GO:0001701
GeneOntologyBiologicalProcess	animal organ morphogenesis	ERBB4 TRAF6 MAN2A1 DSCAML1 RYR1 ESRP2 MET FAT1 HEG1 SLC24A4 ACAN PKHD1 SDK1 CNGA3 MED12 PLXNA1 FOXC1 CDON NPR2 COMP TNC FAT3 WNT2B MUC19 CHD7 ADAMTS5 RUNX2 MED1 AP3B1 PALB2 BBS7 ZNF335 LRP2 ANKRD24 CSMD1 MAP2K1 MAP2K2 PCNT PROX1 EPHB1	4.92e-05	1269	336	40	GO:0009887
GeneOntologyBiologicalProcess	regulation of cell development	SETD1A RELN TRAF6 MAN2A1 ACTB SPART TNFRSF11A MET TSC22D1 FBXO22 TTBK1 ACAN ATP11C PLXNA1 CDON SEMA6C CYSLTR2 NPR2 HDAC6 AMBRA1 CHD7 MED1 AP3B1 NR1D1 FXR1 ISG15 ZNF335 NR2E1 LRP2 DDRGK1 MACF1 AKAP11 MAP2K1 MAP2K2 CDH4 PROX1	5.15e-05	1095	336	36	GO:0060284
GeneOntologyBiologicalProcess	neuron projection morphogenesis	RELN ACTB ACTG1 SPART POTEKP ITGA4 PAK6 DSCAML1 POTEE MET PLXNA1 SEMA6C NPR2 WDR36 HDAC6 POTEF ATL1 ZNF335 TET1 NR2E1 CNTNAP2 LRP2 MACF1 ELAVL4 POTEI MAP2K1 MAP2K2 CDH4 EPHB1	5.57e-05	802	336	29	GO:0048812
GeneOntologyBiologicalProcess	adherens junction organization	ACTB PTPN23 CDH3 CDH4 CDH6 CDH15 CDH17	5.87e-05	61	336	7	GO:0034332
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	ITGA4 DSCAML1 FAT1 FAT2 SDK1 DSG2 FAT3 PCDHB12 PCDHB3 PTPN23 HMCN1 CDH3 CDH4 CDH6 CDH15 CDH17	6.03e-05	313	336	16	GO:0098742
GeneOntologyBiologicalProcess	synapse organization	RELN ERBB4 ACTB ACTG1 POTEKP CSMD2 SORT1 POTEE PTPN13 GLRB TLN2 ADGRF1 SDK1 PICK1 HDAC6 VEZT TNC POTEF PCDHB3 NBEA SLC6A1 CNTNAP2 APPL1 POTEI CDH6 EPHB1	6.22e-05	685	336	26	GO:0050808
GeneOntologyBiologicalProcess	neuron projection development	RELN ACTB ACTG1 SPART SPIRE1 POTEKP ITGA4 PAK6 DSCAML1 JAK2 POTEE MET HERC1 ADGRF1 SDK1 SDC4 PLXNA1 SEMA6C NPR2 WDR36 HDAC6 TNC POTEF FAT3 ROR1 FRYL ATL1 ZNF335 TET1 NR2E1 CNTNAP2 LRP2 MACF1 ELAVL4 ANKRD24 POTEI MAP2K1 MAP2K2 CDH4 EPHB1	6.47e-05	1285	336	40	GO:0031175
GeneOntologyBiologicalProcess	positive regulation of cell development	RELN TRAF6 MAN2A1 ACTB TNFRSF11A MET TTBK1 ACAN ATP11C PLXNA1 CDON HDAC6 AMBRA1 AP3B1 FXR1 ZNF335 NR2E1 LRP2 DDRGK1 MACF1 AKAP11 MAP2K1 MAP2K2 CDH4	7.62e-05	614	336	24	GO:0010720
GeneOntologyBiologicalProcess	cellular pigmentation	AP1B1 BACE2 GPR143 AP3B1 BBS7 MAP2K1 CDH3	8.01e-05	64	336	7	GO:0033059
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	RELN ACTB ACTG1 SPART POTEKP ITGA4 PAK6 DSCAML1 POTEE MET PLXNA1 SEMA6C NPR2 WDR36 HDAC6 POTEF ATL1 ZNF335 TET1 NR2E1 CNTNAP2 LRP2 MACF1 ELAVL4 POTEI MAP2K1 MAP2K2 CDH4 EPHB1	8.05e-05	819	336	29	GO:0120039
GeneOntologyBiologicalProcess	embryo development	ERBB4 TRAF6 MAN2A1 ITGA4 LRP1B DSCAML1 ITPK1 KPNA7 HEG1 BRCA2 SUPT6H BTF3 CC2D2A PLCG1 CPLANE1 MED12 SDC4 FOXC1 CDON SUPT20H RTCB VEZT POLE WNT2B SLC34A2 AMBRA1 CHD7 RUNX2 MED1 PALB2 PPP4R4 KMT2D SF3B1 BBS7 ZNF335 TET1 CNTNAP2 LRP2 MACF1 ANKRD24 MAP2K1 PCNT PROX1	8.32e-05	1437	336	43	GO:0009790
GeneOntologyBiologicalProcess	cell projection morphogenesis	RELN ACTB ACTG1 SPART POTEKP ITGA4 PAK6 DSCAML1 POTEE MET PLXNA1 SEMA6C NPR2 WDR36 HDAC6 POTEF ATL1 ZNF335 TET1 NR2E1 CNTNAP2 LRP2 MACF1 ELAVL4 POTEI MAP2K1 MAP2K2 CDH4 EPHB1	9.34e-05	826	336	29	GO:0048858
GeneOntologyBiologicalProcess	cell-cell junction assembly	ACTB ACTG1 TLN2 TLN1 CNTNAP2 FSCN1 CDH3 CDH4 CDH6 CDH15 CDH17	9.60e-05	167	336	11	GO:0007043
GeneOntologyBiologicalProcess	multicellular organismal-level homeostasis	SETD1A ERBB4 ABCA3 TRAF6 SPTA1 ACTB ACTG1 TNFRSF11A BDKRB2 JAK2 COL14A1 FOXC1 WDR36 HDAC6 COMP GRB10 NBEA LRRK1 ADAMTS5 TEX15 MED1 AP3B1 NR1D1 EPG5 PACS1 ISG15 C1QTNF9 CNTNAP2 SLC28A2 AKAP11 CDH3 BBS12 MUC6 TJP3	9.89e-05	1043	336	34	GO:0048871
GeneOntologyBiologicalProcess	regulation of nervous system development	RELN MAN2A1 SPART MET PTPN13 TTBK1 ACAN PLXNA1 CDON SEMA6C CYSLTR2 HDAC6 CHD7 NR1D1 FXR1 ZNF335 NR2E1 LRP2 MACF1 MAP2K1 MAP2K2 CDH4 PROX1 EPHB1	1.00e-04	625	336	24	GO:0051960
GeneOntologyBiologicalProcess	cell-cell adhesion mediated by cadherin	NEXMIF CDH3 CDH4 CDH6 CDH15 CDH17	1.55e-04	50	336	6	GO:0044331
GeneOntologyBiologicalProcess	cell junction assembly	RELN ERBB4 ACTB ACTG1 CSMD2 PTPN13 TLN2 ADGRF1 SDK1 SDC4 PCDHB3 TLN1 CNTNAP2 MACF1 PEAK1 FSCN1 CDH3 CDH4 CDH6 CDH15 CDH17 EPHB1	1.77e-04	569	336	22	GO:0034329
GeneOntologyBiologicalProcess	calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	PCDHB3 CDH3 CDH4 CDH6 CDH15 CDH17	2.15e-04	53	336	6	GO:0016339
GeneOntologyBiologicalProcess	actin filament-based process	PDE4D SPTA1 ACTB ACTG1 SPIRE1 POTEKP JAK2 POTEE MET FAT1 TLN2 MICAL3 SDC4 PICK1 FLNC CDC42BPA HDAC6 DSG2 POTEF KANK2 ATXN3L HMCN1 TLN1 MYO1F AKAP11 FHDC1 POTEI FSCN1 ATP2A2 PROX1	2.20e-04	912	336	30	GO:0030029
GeneOntologyBiologicalProcess	biphenyl catabolic process	UGT2B4 UGT2B7 UGT2B10	2.26e-04	8	336	3	GO:0070980
GeneOntologyBiologicalProcess	olfactory nerve development	SLC24A4 PLXNA1 CHD7	2.26e-04	8	336	3	GO:0021553
GeneOntologyBiologicalProcess	protein localization to organelle	ERBB4 TRAF6 NCLN SORT1 JAK2 KPNA7 BRCA2 TOMM40L BTF3 PEX19 CC2D2A CPLANE1 KPNB1 RANBP2 MIA3 PTPN23 NBEA TEX15 MED1 AP3B1 PACS1 ISG15 CCT5 TRAPPC12 CEP83 LRP2 IPO13 DDRGK1 MACF1 APPL1 HACL1 AKAP11 MORC3 MAP2K1	2.30e-04	1091	336	34	GO:0033365
GeneOntologyBiologicalProcess	neuron development	RELN ACTB ACTG1 SPART SPIRE1 POTEKP ITGA4 PAK6 DSCAML1 JAK2 POTEE MET HERC1 ADGRF1 SDK1 CNGA3 SDC4 PLXNA1 PICK1 SEMA6C NPR2 WDR36 HDAC6 TNC POTEF FAT3 ROR1 FRYL ATL1 ZNF335 TET1 NR2E1 CNTNAP2 LRP2 MACF1 ELAVL4 ANKRD24 POTEI MAP2K1 MAP2K2 CDH4 EPHB1	2.47e-04	1463	336	42	GO:0048666
GeneOntologyBiologicalProcess	positive regulation of neurogenesis	RELN MAN2A1 MET TTBK1 ACAN PLXNA1 CDON HDAC6 FXR1 ZNF335 NR2E1 LRP2 MACF1 MAP2K1 MAP2K2 CDH4	2.48e-04	354	336	16	GO:0050769
GeneOntologyBiologicalProcess	calcium ion transport from cytosol to endoplasmic reticulum	ATP2A2 ATP2A3	2.65e-04	2	336	2	GO:1903515
GeneOntologyBiologicalProcess	regulation of melanosome transport	GPR143 CDH3	2.65e-04	2	336	2	GO:1902908
GeneOntologyBiologicalProcess	actin cytoskeleton organization	SPTA1 ACTB ACTG1 SPIRE1 POTEKP JAK2 POTEE MET FAT1 TLN2 MICAL3 SDC4 PICK1 FLNC CDC42BPA HDAC6 POTEF KANK2 ATXN3L HMCN1 TLN1 MYO1F AKAP11 FHDC1 POTEI FSCN1 PROX1	3.24e-04	803	336	27	GO:0030036
GeneOntologyBiologicalProcess	positive regulation of neural precursor cell proliferation	SETD1A ACAN CDON ZNF335 NR2E1 LRP2 PROX1	3.28e-04	80	336	7	GO:2000179
GeneOntologyBiologicalProcess	ventricular cardiac muscle tissue morphogenesis	HEG1 FOXC1 CHD7 MED1 LRP2 PROX1	3.89e-04	59	336	6	GO:0055010
GeneOntologyBiologicalProcess	melanosome transport	GPR143 BBS7 MAP2K1 CDH3	4.01e-04	22	336	4	GO:0032402
GeneOntologyBiologicalProcess	muscle structure development	ACTB ACTG1 RYR1 SORT1 MET HEG1 FBXO22 SUPT6H ALPK3 COL14A1 FOXK1 FOXC1 CDON COL6A3 FLNC HDAC6 COMP CHD7 ADAMTS5 MED1 PIAS1 FXR1 FRG1 CNTNAP2 LRP2 ATP2A2 PROX1 EPHB1	4.05e-04	858	336	28	GO:0061061
GeneOntologyBiologicalProcess	positive regulation of epithelial cell apoptotic process	ITGA4 SORT1 JAK2 PLCG1 CD160 PLA2R1	4.27e-04	60	336	6	GO:1904037
GeneOntologyBiologicalProcess	biphenyl metabolic process	UGT2B4 UGT2B7 UGT2B10	4.72e-04	10	336	3	GO:0018879
GeneOntologyBiologicalProcess	pigment granule transport	GPR143 BBS7 MAP2K1 CDH3	4.79e-04	23	336	4	GO:0051904
GeneOntologyBiologicalProcess	establishment of melanosome localization	GPR143 BBS7 MAP2K1 CDH3	4.79e-04	23	336	4	GO:0032401
GeneOntologyBiologicalProcess	startle response	GLRA1 GLRB NPR2 CNTNAP2 CSMD1	5.16e-04	41	336	5	GO:0001964
GeneOntologyBiologicalProcess	xenobiotic metabolic process	CYP2C18 ACAA1 CYP3A5 UGT2B4 UGT2B7 UGT2B10 CYP3A43 SLC28A2 ABCB11	5.17e-04	141	336	9	GO:0006805
GeneOntologyBiologicalProcess	epithelium development	ERBB4 TRAF6 PDE4D ACTB ACTG1 ITGA4 ITPK1 ESRP2 JAK2 MET FAT1 HEG1 BRCA2 PKHD1 CC2D2A CPLANE1 MED12 SDC4 PLXNA1 FOXC1 NPR2 TNC WNT2B XDH AMBRA1 CHD7 MED1 AP3B1 KANK2 PALB2 BBS7 LRP2 AKAP11 ANKRD24 CSMD1 MAP2K1 MAP2K2 CDH3 PCNT PROX1 TJP3	5.21e-04	1469	336	41	GO:0060429
GeneOntologyBiologicalProcess	positive regulation of nervous system development	RELN MAN2A1 MET TTBK1 ACAN PLXNA1 CDON HDAC6 FXR1 ZNF335 NR2E1 LRP2 MACF1 MAP2K1 MAP2K2 CDH4 EPHB1	5.42e-04	418	336	17	GO:0051962
GeneOntologyBiologicalProcess	head development	SETD1A RELN ERBB4 ACTB ITGA4 DSCAML1 POTEE MET TTBK1 BRCA2 HERC1 CPLANE1 PLXNA1 FOXC1 CDON CHD7 MED1 FXR1 BBS7 ZNF335 NR2E1 CNTNAP2 LRP2 ELAVL4 MAP2K1 MAP2K2 PCNT PROX1 EPHB1	5.49e-04	919	336	29	GO:0060322
GeneOntologyBiologicalProcess	establishment of pigment granule localization	GPR143 BBS7 MAP2K1 CDH3	5.68e-04	24	336	4	GO:0051905
GeneOntologyBiologicalProcess	tissue morphogenesis	ERBB4 TRAF6 ACTB ACTG1 ESRP2 MET FAT1 HEG1 PKHD1 CC2D2A CPLANE1 MED12 SDC4 PLXNA1 FOXC1 TNC WNT2B CHD7 ADAMTS5 MED1 BBS7 LRP2 MACF1 CSMD1 PROX1	6.10e-04	750	336	25	GO:0048729
GeneOntologyCellularComponent	NuA4 histone acetyltransferase complex	ACTB ACTG1 POTEKP TRRAP POTEE BRD8 POTEF POTEI	3.23e-08	32	338	8	GO:0035267
GeneOntologyCellularComponent	H4/H2A histone acetyltransferase complex	ACTB ACTG1 POTEKP TRRAP POTEE BRD8 POTEF POTEI	3.23e-08	32	338	8	GO:0043189
GeneOntologyCellularComponent	cell-cell junction	ACTB ACTG1 ITGA4 FRMD4B ADCYAP1R1 FAT1 FAT2 HEG1 TLN2 PLCG1 CDC42BPA DSG2 VEZT SYNM HMCN1 TLN1 CNTNAP2 ABCB11 FSCN1 MAP2K2 ATP2A2 CDH3 CDH4 CDH6 CDH15 CDH17 SYMPK TJP3	4.30e-07	591	338	28	GO:0005911
GeneOntologyCellularComponent	H4 histone acetyltransferase complex	ACTB ACTG1 POTEKP TRRAP POTEE BRD8 POTEF POTEI	5.51e-07	45	338	8	GO:1902562
GeneOntologyCellularComponent	costamere	ACTG1 CMYA5 SDC4 FLNC SYNM FXR1	1.03e-06	22	338	6	GO:0043034
GeneOntologyCellularComponent	histone acetyltransferase complex	ACTB ACTG1 POTEKP TRRAP POTEE BRD8 SUPT20H POTEF TAF5L POTEI	2.91e-06	94	338	10	GO:0000123
GeneOntologyCellularComponent	anchoring junction	ACTB ACTG1 ITGA4 FRMD4B ADCYAP1R1 JAK2 FAT1 FAT2 HEG1 TLN2 PLCG1 SDC4 FLNC CDC42BPA DSG2 VEZT SYNM TNC AMBRA1 HMCN1 TLN1 CNTNAP2 ABCB11 PEAK1 FSCN1 MAP2K1 MAP2K2 FYB1 ATP2A2 CDH3 CDH4 CDH6 CDH15 CDH17 SYMPK TJP3	3.74e-06	976	338	36	GO:0070161
GeneOntologyCellularComponent	protein acetyltransferase complex	ACTB ACTG1 POTEKP TRRAP POTEE BRD8 SUPT20H POTEF TAF5L POTEI	7.27e-06	104	338	10	GO:0031248
GeneOntologyCellularComponent	catenin complex	APC2 CDH3 CDH4 CDH6 CDH15 CDH17	1.09e-05	32	338	6	GO:0016342
GeneOntologyCellularComponent	acetyltransferase complex	ACTB ACTG1 POTEKP TRRAP POTEE BRD8 SUPT20H POTEF TAF5L POTEI	1.11e-05	109	338	10	GO:1902493
GeneOntologyCellularComponent	extrinsic component of plasma membrane	TRAF6 APC2 RYR1 JAK2 ATP2A2 CDH3 CDH4 CDH6 CDH15 CDH17	7.99e-05	137	338	10	GO:0019897
GeneOntologyCellularComponent	cell cortex	TRAF6 SPTA1 ACTB SPIRE1 RYR1 MICAL3 EXOC7 POTEF FRYL CLIP4 HMCN1 MYO1F MACF1 EXOC1 FSCN1 MAP2K1 MAP2K2	1.25e-04	371	338	17	GO:0005938
GeneOntologyCellularComponent	adherens junction	ACTB FRMD4B FAT2 VEZT SYNM HMCN1 TLN1 CDH3 CDH4 CDH6 CDH15 CDH17	1.84e-04	212	338	12	GO:0005912
GeneOntologyCellularComponent	glycine-gated chloride channel complex	GLRB GLRA3	2.61e-04	2	338	2	GO:0016935
GeneOntologyCellularComponent	axon	RELN SPTA1 ACTB ACTG1 POTEKP ITGA4 DSCAML1 POTEE GLRA1 NAV1 EXOC7 CNGA3 HDAC6 POTEF ROR1 AP3B1 ATL1 SLC6A1 FXR1 PEBP1 CNTNAP2 LRP2 ELAVL4 WDFY3 POTEI FSCN1 MAP2K1 UNC80 EPHB1	2.96e-04	891	338	29	GO:0030424
GeneOntologyCellularComponent	sarcoplasm	CMYA5 RYR1 RYR3 FLNC XDH POMT1 ATP2A2 ATP2A3	5.36e-04	114	338	8	GO:0016528
GeneOntologyCellularComponent	sarcoplasmic reticulum	CMYA5 RYR1 RYR3 XDH POMT1 ATP2A2 ATP2A3	5.62e-04	88	338	7	GO:0016529
GeneOntologyCellularComponent	actin filament	APC2 ACTB ACTG1 POTEKP POTEE POTEF MYO1F FHDC1 POTEI	6.31e-04	146	338	9	GO:0005884
GeneOntologyCellularComponent	perinuclear region of cytoplasm	TRAF6 PDE4D APC2 SPIRE1 CMYA5 RYR1 RYR3 SORT1 FAT1 TTBK1 STX4 PKHD1 PICK1 HSP90AA4P NPC1 TLK2 RANBP2 HDAC6 VPS50 AMBRA1 EPG5 PACS1 FXR1 TRAPPC12 ASL EXOC1 MAP2K1 MAP2K2 ATP2A2	6.33e-04	934	338	29	GO:0048471
GeneOntologyCellularComponent	INO80-type complex	GON4L TRRAP BRD8 YY1AP1	1.01e-03	28	338	4	GO:0097346
GeneOntologyCellularComponent	cluster of actin-based cell projections	ACTB PEX19 TMC2 VEZT SLC34A2 PKHD1L1 SLC28A2 SLC28A1 LRP2 ANKRD24 SLC26A6	1.06e-03	223	338	11	GO:0098862
GeneOntologyCellularComponent	supramolecular fiber	PDE4D APC2 ACTB ACTG1 POTEKP CMYA5 RYR1 RYR3 POTEE FBXO22 EML5 NAV1 DNAH9 SDC4 TLK2 COL6A3 FLNC HDAC6 SYNM POTEF CLIP4 FXR1 CCT5 FRG1 SPHKAP MYO1F MACF1 FHDC1 POTEI MAP2K1 MAP2K2 PBXIP1 PCNT	1.57e-03	1179	338	33	GO:0099512
GeneOntologyCellularComponent	myofibril	PDE4D ACTG1 CMYA5 RYR1 RYR3 FBXO22 SDC4 FLNC SYNM FXR1 FRG1 SPHKAP	1.72e-03	273	338	12	GO:0030016
GeneOntologyCellularComponent	supramolecular polymer	PDE4D APC2 ACTB ACTG1 POTEKP CMYA5 RYR1 RYR3 POTEE FBXO22 EML5 NAV1 DNAH9 SDC4 TLK2 COL6A3 FLNC HDAC6 SYNM POTEF CLIP4 FXR1 CCT5 FRG1 SPHKAP MYO1F MACF1 FHDC1 POTEI MAP2K1 MAP2K2 PBXIP1 PCNT	1.75e-03	1187	338	33	GO:0099081
GeneOntologyCellularComponent	cell projection membrane	APC2 STX4 PEX19 PLCG1 VEZT SLC34A2 BBS7 TLN1 CNTNAP2 SLC28A2 SLC28A1 LRP2 MACF1 SYTL1 FSCN1 SLC26A6	1.87e-03	431	338	16	GO:0031253
Domain	DUF4704	NBEAL2 NBEA WDFY3 LRBA	5.01e-07	5	335	4	IPR031570
Domain	DUF4704	NBEAL2 NBEA WDFY3 LRBA	5.01e-07	5	335	4	PF15787
Domain	PH_BEACH	NBEAL2 NBEA WDFY3 LRBA	1.48e-06	6	335	4	PF14844
Domain	ARM-like	APC2 TRRAP KPNA7 AP1B1 NBEAL2 MED12 KPNB1 NBEA FRYL ARMCX5 AP3B1 PPP4R4 SF3B1 IPO13 WDFY3 LRBA XPOT SYMPK	2.00e-06	270	335	18	IPR011989
Domain	-	APC2 TRRAP KPNA7 AP1B1 MED12 KPNB1 FRYL ARMCX5 AP3B1 PPP4R4 SF3B1 IPO13 WDFY3 LRBA XPOT SYMPK	2.73e-06	222	335	16	1.25.10.10
Domain	Cadherin_CS	FAT1 FAT2 DSG2 FAT3 PCDHB12 PCDHB3 CDH3 CDH4 CDH6 CDH15 CDH17	4.21e-06	109	335	11	IPR020894
Domain	CADHERIN_1	FAT1 FAT2 DSG2 FAT3 PCDHB12 PCDHB3 CDH3 CDH4 CDH6 CDH15 CDH17	5.98e-06	113	335	11	PS00232
Domain	Cadherin	FAT1 FAT2 DSG2 FAT3 PCDHB12 PCDHB3 CDH3 CDH4 CDH6 CDH15 CDH17	5.98e-06	113	335	11	PF00028
Domain	-	FAT1 FAT2 DSG2 FAT3 PCDHB12 PCDHB3 CDH3 CDH4 CDH6 CDH15 CDH17	6.52e-06	114	335	11	2.60.40.60
Domain	CADHERIN_2	FAT1 FAT2 DSG2 FAT3 PCDHB12 PCDHB3 CDH3 CDH4 CDH6 CDH15 CDH17	6.52e-06	114	335	11	PS50268
Domain	Actin_CS	ACTB ACTG1 POTEE POTEF POTEI	6.69e-06	16	335	5	IPR004001
Domain	PH_BEACH	NBEAL2 NBEA WDFY3 LRBA	6.72e-06	8	335	4	PS51783
Domain	PH-BEACH_dom	NBEAL2 NBEA WDFY3 LRBA	6.72e-06	8	335	4	IPR023362
Domain	-	NBEAL2 NBEA WDFY3 LRBA	6.72e-06	8	335	4	2.30.29.40
Domain	CA	FAT1 FAT2 DSG2 FAT3 PCDHB12 PCDHB3 CDH3 CDH4 CDH6 CDH15 CDH17	7.09e-06	115	335	11	SM00112
Domain	Cadherin-like	FAT1 FAT2 DSG2 FAT3 PCDHB12 PCDHB3 CDH3 CDH4 CDH6 CDH15 CDH17	7.71e-06	116	335	11	IPR015919
Domain	Cadherin	FAT1 FAT2 DSG2 FAT3 PCDHB12 PCDHB3 CDH3 CDH4 CDH6 CDH15 CDH17	9.09e-06	118	335	11	IPR002126
Domain	ACTINS_2	ACTB ACTG1 POTEE POTEF POTEI	9.34e-06	17	335	5	PS00432
Domain	-	FSTL5 EDC4 DDB2 SORT1 MET EML5 NBEAL2 HERC1 PLXNA1 SEMA6C WDR36 WDR70 AMBRA1 NBEA PALB2 BBS7 TAF5L WDFY3 LRBA	1.00e-05	333	335	19	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	FSTL5 EDC4 DDB2 SORT1 MET EML5 NBEAL2 HERC1 PLXNA1 SEMA6C WDR36 WDR70 AMBRA1 NBEA PALB2 BBS7 TAF5L WDFY3 LRBA	1.09e-05	335	335	19	IPR015943
Domain	BEACH	NBEAL2 NBEA WDFY3 LRBA	1.19e-05	9	335	4	PS50197
Domain	Beach	NBEAL2 NBEA WDFY3 LRBA	1.19e-05	9	335	4	SM01026
Domain	BEACH_dom	NBEAL2 NBEA WDFY3 LRBA	1.19e-05	9	335	4	IPR000409
Domain	Beach	NBEAL2 NBEA WDFY3 LRBA	1.19e-05	9	335	4	PF02138
Domain	-	NBEAL2 NBEA WDFY3 LRBA	1.19e-05	9	335	4	1.10.1540.10
Domain	Actin/actin-like_CS	ACTB ACTG1 POTEE POTEF POTEI	1.27e-05	18	335	5	IPR020902
Domain	ARM-type_fold	APC2 TRRAP RYR3 KPNA7 AP1B1 NBEAL2 KPNB1 NBEA FRYL ARMCX5 AP3B1 PPP4R4 ARFGEF3 SF3B1 IPO13 WDFY3 LRBA XPOT SYMPK	1.29e-05	339	335	19	IPR016024
Domain	ACTINS_ACT_LIKE	ACTB ACTG1 POTEE POTEF POTEI	1.70e-05	19	335	5	PS01132
Domain	ConA-like_dom	CMYA5 RYR1 RYR3 FAT1 FAT2 NBEAL2 COL14A1 HERC1 COMP FAT3 NBEA CNTNAP2 WDFY3 LRBA	4.37e-05	219	335	14	IPR013320
Domain	K/Na/Ca-exchanger	SLC24A5 SLC24A4 SLC24A2	5.57e-05	5	335	3	IPR004481
Domain	Cadherin_C	DSG2 CDH3 CDH4 CDH6 CDH15	7.13e-05	25	335	5	PF01049
Domain	Cadherin_cytoplasmic-dom	DSG2 CDH3 CDH4 CDH6 CDH15	7.13e-05	25	335	5	IPR000233
Domain	TIL_dom	VWF MUC19 LRP2 MUC6	8.83e-05	14	335	4	IPR002919
Domain	Catenin_binding_dom	DSG2 CDH3 CDH4 CDH6 CDH15	1.50e-04	29	335	5	IPR027397
Domain	-	DSG2 CDH3 CDH4 CDH6 CDH15	1.50e-04	29	335	5	4.10.900.10
Domain	Actin	ACTB ACTG1 POTEE POTEF POTEI	2.09e-04	31	335	5	IPR004000
Domain	Actin	ACTB ACTG1 POTEE POTEF POTEI	2.09e-04	31	335	5	PF00022
Domain	ACTIN	ACTB ACTG1 POTEE POTEF POTEI	2.09e-04	31	335	5	SM00268
Domain	-	FAT1 FAT2 COMP FAT3 NBEA CNTNAP2 WDFY3 LRBA	3.09e-04	95	335	8	2.60.120.200
Domain	-	TLN2 TLN1	3.21e-04	2	335	2	1.20.1420.10
Domain	VBS	TLN2 TLN1	3.21e-04	2	335	2	PF08913
Domain	Talin_cent	TLN2 TLN1	3.21e-04	2	335	2	IPR015224
Domain	Talin_middle	TLN2 TLN1	3.21e-04	2	335	2	PF09141
Domain	DUF1088	NBEA LRBA	3.21e-04	2	335	2	PF06469
Domain	DUF1088	NBEA LRBA	3.21e-04	2	335	2	IPR010508
Domain	Vinculin-bd_dom	TLN2 TLN1	3.21e-04	2	335	2	IPR015009
Domain	WD40_repeat_dom	EDC4 DDB2 EML5 NBEAL2 HERC1 WDR36 WDR70 AMBRA1 NBEA LRRK1 PALB2 BBS7 TAF5L WDFY3 LRBA	3.25e-04	297	335	15	IPR017986
Domain	Kinase-like_dom	ERBB4 PAK6 TRRAP JAK2 MET PTPN13 TTBK1 ALPK3 MAP3K19 TLK2 NPR2 CDC42BPA ROR1 LRRK1 NRBP2 GUCY2F MAP4K5 MACF1 PEAK1 MAP2K1 MAP2K2 EPHB1	3.37e-04	542	335	22	IPR011009
Domain	NaCa_Exmemb	SLC24A5 SLC24A4 SLC24A2	4.43e-04	9	335	3	IPR004837
Domain	Na_Ca_ex	SLC24A5 SLC24A4 SLC24A2	4.43e-04	9	335	3	PF01699
Domain	MIR	RYR1 RYR3 POMT1	6.25e-04	10	335	3	PF02815
Domain	MIR_motif	RYR1 RYR3 POMT1	6.25e-04	10	335	3	IPR016093
Domain	MIR	RYR1 RYR3 POMT1	6.25e-04	10	335	3	PS50919
Domain	MIR	RYR1 RYR3 POMT1	6.25e-04	10	335	3	SM00472
Domain	EGF_CA	LRP1B FAT1 HEG1 COMP FAT3 HMCN1 LRP2	8.97e-04	86	335	7	PF07645
Domain	CNT_C_dom	SLC28A2 SLC28A1	9.51e-04	3	335	2	IPR011657
Domain	C_nuclsd_transpt_met_bac	SLC28A2 SLC28A1	9.51e-04	3	335	2	IPR018270
Domain	Gate_dom	SLC28A2 SLC28A1	9.51e-04	3	335	2	IPR011642
Domain	Nucleos_tra2_C	SLC28A2 SLC28A1	9.51e-04	3	335	2	PF07662
Domain	Gate	SLC28A2 SLC28A1	9.51e-04	3	335	2	PF07670
Domain	CNT_N_dom	SLC28A2 SLC28A1	9.51e-04	3	335	2	IPR002668
Domain	RyR	RYR1 RYR3	9.51e-04	3	335	2	PF02026
Domain	Asparaginase_2	AGA ASRGL1	9.51e-04	3	335	2	PF01112
Domain	RR_TM4-6	RYR1 RYR3	9.51e-04	3	335	2	PF06459
Domain	P-type_ATPase_IIA	ATP2A2 ATP2A3	9.51e-04	3	335	2	IPR005782
Domain	Ryan_recept	RYR1 RYR3	9.51e-04	3	335	2	IPR013333
Domain	C_nuclsd_transpt	SLC28A2 SLC28A1	9.51e-04	3	335	2	IPR008276
Domain	Nucleos_tra2_N	SLC28A2 SLC28A1	9.51e-04	3	335	2	PF01773
Domain	Ryanodine_rcpt	RYR1 RYR3	9.51e-04	3	335	2	IPR003032
Domain	Peptidase_T2	AGA ASRGL1	9.51e-04	3	335	2	IPR000246
Domain	Talin-1	TLN2 TLN1	9.51e-04	3	335	2	IPR015710
Domain	Ryanrecept_TM4-6	RYR1 RYR3	9.51e-04	3	335	2	IPR009460
Domain	DUF4599	SPATA31A7 SPATA31A3 SPATA31A5	1.12e-03	12	335	3	PF15371
Domain	DUF4599	SPATA31A7 SPATA31A3 SPATA31A5	1.12e-03	12	335	3	IPR027970
Domain	C8	VWF MUC19 MUC6	1.12e-03	12	335	3	PF08742
Domain	TIL	VWF MUC19 MUC6	1.12e-03	12	335	3	PF01826
Domain	IPT	MET PKHD1 PLXNA1 PKHD1L1	1.29e-03	27	335	4	SM00429
Domain	C8	VWF MUC19 MUC6	1.43e-03	13	335	3	SM00832
Domain	Unchr_dom_Cys-rich	VWF MUC19 MUC6	1.43e-03	13	335	3	IPR014853
Domain	Armadillo	APC2 KPNA7 AP1B1 KPNB1 ARMCX5	1.49e-03	47	335	5	IPR000225
Domain	WD_REPEATS_1	EDC4 DDB2 EML5 NBEAL2 HERC1 WDR36 WDR70 AMBRA1 NBEA PALB2 TAF5L WDFY3 LRBA	1.61e-03	278	335	13	PS00678
Domain	EGF_CA	LRP1B FAT1 FAT2 HEG1 COMP FAT3 HMCN1 LRP2	1.62e-03	122	335	8	SM00179
Domain	WD_REPEATS_2	EDC4 DDB2 EML5 NBEAL2 HERC1 WDR36 WDR70 AMBRA1 NBEA PALB2 TAF5L WDFY3 LRBA	1.66e-03	279	335	13	PS50082
Domain	WD_REPEATS_REGION	EDC4 DDB2 EML5 NBEAL2 HERC1 WDR36 WDR70 AMBRA1 NBEA PALB2 TAF5L WDFY3 LRBA	1.66e-03	279	335	13	PS50294
Domain	UCH	USP17L7 USP17L1 USP17L3 USP17L4 USP17L10 USP17L8	1.71e-03	71	335	6	PF00443
Domain	USP_2	USP17L7 USP17L1 USP17L3 USP17L4 USP17L10 USP17L8	1.71e-03	71	335	6	PS00973
Domain	EGF-like_Ca-bd_dom	LRP1B FAT1 FAT2 HEG1 COMP FAT3 HMCN1 LRP2	1.79e-03	124	335	8	IPR001881
Domain	FERM_central	FRMD4B JAK2 PTPN13 TLN2 TLN1	1.80e-03	49	335	5	IPR019748
Domain	FERM_domain	FRMD4B JAK2 PTPN13 TLN2 TLN1	1.80e-03	49	335	5	IPR000299
Domain	EGF_Ca-bd_CS	LRP1B FAT1 HEG1 COMP FAT3 HMCN1 LRP2	1.81e-03	97	335	7	IPR018097
Domain	USP_dom	USP17L7 USP17L1 USP17L3 USP17L4 USP17L10 USP17L8	1.84e-03	72	335	6	IPR028889
Domain	Peptidase_C19_UCH	USP17L7 USP17L1 USP17L3 USP17L4 USP17L10 USP17L8	1.84e-03	72	335	6	IPR001394
Domain	USP_3	USP17L7 USP17L1 USP17L3 USP17L4 USP17L10 USP17L8	1.84e-03	72	335	6	PS50235
Domain	Fumarylacetoacetase_C-rel	FAHD2B FAHD2A	1.88e-03	4	335	2	IPR011234
Domain	FAA_hydrolase	FAHD2B FAHD2A	1.88e-03	4	335	2	PF01557
Domain	FERM_f0	TLN2 TLN1	1.88e-03	4	335	2	PF16511
Domain	Actin_cross-linking	FRG1 FSCN1	1.88e-03	4	335	2	IPR008999
Domain	G8	PKHD1 PKHD1L1	1.88e-03	4	335	2	PS51484
Domain	ILWEQ	TLN2 TLN1	1.88e-03	4	335	2	PD011820
Domain	B2-adapt-app_C	AP1B1 AP3B1	1.88e-03	4	335	2	SM01020
Pathway	REACTOME_CELL_CELL_COMMUNICATION	ACTB ACTG1 SFTPA2 SFTPA1 SDK1 FLNC FYB1 CDH3 CDH4 CDH6 CDH15 CDH17	2.15e-07	96	263	12	MM14592
Pathway	REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS	ACTB ACTG1 JAK2 VWF AP3B1 FXR1 PEBP1 TLN1 MAP2K1 MAP2K2	3.13e-07	65	263	10	M38994
Pathway	REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS	ACTB ACTG1 JAK2 VWF PEBP1 TLN1 MAP2K1 MAP2K2	1.56e-06	45	263	8	M27623
Pathway	REACTOME_CELL_CELL_JUNCTION_ORGANIZATION	ACTB ACTG1 SDK1 CDH3 CDH4 CDH6 CDH15 CDH17	2.61e-06	48	263	8	MM15069
Pathway	REACTOME_ONCOGENIC_MAPK_SIGNALING	ACTB ACTG1 JAK2 VWF AP3B1 FXR1 PEBP1 TLN1 MAP2K1 MAP2K2	2.83e-06	82	263	10	M27626
Pathway	REACTOME_MAP2K_AND_MAPK_ACTIVATION	ACTB ACTG1 VWF PEBP1 TLN1 MAP2K1 MAP2K2	6.71e-06	39	263	7	MM15272
Pathway	REACTOME_MAP2K_AND_MAPK_ACTIVATION	ACTB ACTG1 VWF PEBP1 TLN1 MAP2K1 MAP2K2	8.00e-06	40	263	7	M27557
Pathway	REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS	ACTB ACTG1 CDH3 CDH4 CDH6 CDH15 CDH17	8.00e-06	40	263	7	MM15060
Pathway	REACTOME_CELL_JUNCTION_ORGANIZATION	ACTB ACTG1 SDK1 FLNC CDH3 CDH4 CDH6 CDH15 CDH17	8.18e-06	73	263	9	MM15126
Pathway	KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAB_C_D_TO_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY	ACTB ACTG1 TLN2 TLN1	1.39e-05	9	263	4	M47725
Pathway	KEGG_FOCAL_ADHESION	RELN ACTB ACTG1 ITGA4 PAK6 MET TLN2 COL6A3 FLNC VWF COMP TNC TLN1 MAP2K1	2.22e-05	199	263	14	M7253
Pathway	REACTOME_DISEASES_ASSOCIATED_WITH_SURFACTANT_METABOLISM	ABCA3 SFTPA2 SFTPA1 SLC34A2	2.28e-05	10	263	4	M27573
Pathway	REACTOME_CELL_CELL_COMMUNICATION	ACTB ACTG1 SFTPA2 SFTPA1 SDK1 FLNC FYB1 CDH3 CDH4 CDH6 CDH15 CDH17	3.38e-05	155	263	12	M522
Pathway	REACTOME_PREDNISONE_ADME	CYP3A5 UGT2B4 UGT2B7 UGT2B10 CYP3A43	5.56e-05	23	263	5	MM16639
Pathway	WP_FOCAL_ADHESION	RELN ACTB ACTG1 ITGA4 PAK6 MET TLN2 FLNC VWF COMP TNC TLN1 MAP2K1	9.35e-05	199	263	13	M39402
Pathway	REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS	ACTB ACTG1 CDH3 CDH4 CDH6 CDH15 CDH17	9.69e-05	58	263	7	M11980
Pathway	REACTOME_MAPK_FAMILY_SIGNALING_CASCADES	USP17L7 ERBB4 USP17L1 SPTA1 ACTB ACTG1 JAK2 MET USP17L3 USP17L4 VWF USP17L10 PEBP1 TLN1 MAP2K1 MAP2K2 USP17L8	1.01e-04	318	263	17	MM15278
Pathway	REACTOME_RAS_PROCESSING	USP17L7 USP17L1 USP17L3 USP17L4 USP17L10 USP17L8	1.76e-04	45	263	6	MM15671
Pathway	KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY	ACTB ACTG1 ITGA4 TLN2 TLN1	2.12e-04	30	263	5	M47724
Pathway	REACTOME_CELL_CELL_JUNCTION_ORGANIZATION	ACTB ACTG1 SDK1 CDH3 CDH4 CDH6 CDH15 CDH17	2.73e-04	90	263	8	M820
Pathway	REACTOME_CELL_JUNCTION_ORGANIZATION	ACTB ACTG1 SDK1 FLNC CDH3 CDH4 CDH6 CDH15 CDH17	3.41e-04	117	263	9	M19248
Pathway	KEGG_DRUG_METABOLISM_OTHER_ENZYMES	CYP3A5 UGT2B4 UGT2B7 UGT2B10 CYP3A43 XDH	3.55e-04	51	263	6	M17726
Pathway	REACTOME_NERVOUS_SYSTEM_DEVELOPMENT	RELN SPTA1 ACTB ACTG1 DSCAML1 MET PLCG1 PLXNA1 COL6A3 GRB10 TLN1 MAP2K1 MAP2K2 EPHB1	3.98e-04	261	263	14	MM15676
Pathway	REACTOME_DEUBIQUITINATION	USP17L7 TRAF6 USP17L1 ACTB TRRAP DDB2 NOD1 ABRAXAS1 USP17L3 FOXK1 USP17L4 USP17L10 ATXN3L USP17L8	4.14e-04	262	263	14	MM15286
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	RELN ACAA1 ACTB ZKSCAN8 MET AP1B1 MAGED2 BTF3 ALDH18A1 MICAL3 ACAA2 PRRC2A FLNC MIA3 VWF DSG2 RTCB SYNM PACS1 MAP4K5 TLN1 MACF1 EXOC1 FSCN1 PCBP1 PBXIP1 PCNT PROX1	4.98e-17	360	343	28	33111431
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SETD1A SPIRE1 EDC4 NCLN TRRAP RYR1 ESRP2 JAK2 FAT1 HEG1 STX4 MDN1 NBEAL2 NAV1 CPSF1 TLN2 MICAL3 PLCG1 HERC1 MED12 PLXNA1 MED13 FOXK1 PICK1 NPC1 SEMA6C FLNC CDC42BPA NRF1 POLE WDR70 GRB10 AMBRA1 FRYL LRRK1 NHSL1 KMT2D TRAPPC12 ZNF335 TLN1 WDFY3 LRBA ATP2A3 PCNT SYMPK TJP3	1.95e-16	1105	343	46	35748872
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	MKRN3 DLGAP1 RELN TRAF6 APC2 ACTB ZNF224 CMYA5 LRP1B DSCAML1 FRMD4B RYR3 PTPN13 MAN1A2 TLN2 PLCG1 EXOC7 BACE2 PRRC2A MED13 PICK1 KPNB1 NPC1 VWF SUPT20H HDAC6 SYNM NBEA NR1D1 KANK2 PIAS1 CLIP4 SLC6A1 SF3B1 LRP2 MACF1 APPL1 YY1AP1 ANKRD24 EXOC1 WDFY3 LRBA MORC3 QTRT1 PCBP1 ATP2A2 PBXIP1 XPOT PCNT	5.81e-16	1285	343	49	35914814
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	ACTB EDC4 ITPK1 HSPA12A BRD8 MDN1 AP1B1 MAGED2 CPSF1 TLN2 EXOC7 KPNB1 RANBP2 RTCB POLE CHD7 AP3B1 SF3B1 CCT5 TLN1 GEMIN4 MACF1 EXOC1 GEMIN6 MAP2K2 PCBP1 PCNT SYMPK	7.36e-12	582	343	28	20467437
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ERCC5 CYP2C18 ZNF224 TRRAP MED24 BRD8 MDN1 MAGED2 CPSF1 TLN2 MICAL3 PRRC2A MED13 TLK2 RANBP2 HDAC6 RRP15 CHD7 MED1 NR1D1 PALB2 PACS1 KMT2D SF3B1 ZNF335 APPL1 YY1AP1 MAP2K2 PCBP1 ATP2A2 CDH17 SYMPK	1.19e-11	774	343	32	15302935
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	MAN2A1 ACTB GON4L SPIRE1 EDC4 TRRAP MED24 POTEE BRD8 PTPN13 MAN1A2 MDN1 SUPT6H BTF3 ALDH18A1 SPATS2 PRRC2A MED12 SDC4 MED13 FOXK1 RANBP2 SUPT20H CDC42BPA WDR36 DSG2 RTCB RRP15 CHD7 MED1 PNKD AP3B1 KANK2 PIAS1 CCT5 FRG1 TLN1 CEP83 GEMIN4 TMF1 DDRGK1 MACF1 TAF5L ATP2A2 PBXIP1	3.47e-11	1497	343	45	31527615
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	EDC4 TRRAP MDN1 AP1B1 SUPT6H CPSF1 ALDH18A1 PRRC2A MED12 KPNB1 FLNC RANBP2 WDR36 RTCB POLE FRYL CHD7 FXR1 SF3B1 CCT5 TLN1 GEMIN4 MACF1 FSCN1 ATP2A2 XPOT PCNT SYMPK	1.06e-10	653	343	28	22586326
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	ACTB ACTG1 POTEKP EDC4 PKHD1 CPSF1 PRRC2A NPC1 RANBP2 CDC42BPA POTEF PTPN23 SF3B1 MAP2K1 MAP2K2 ATP2A2	2.15e-10	202	343	16	24639526
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	SETD1A ACTB TRRAP FBXO22 MDN1 MAGED2 CPSF1 ALDH18A1 ACAA2 PRR14L PLCG1 MED12 SDC4 KPNB1 FLNC RANBP2 ANKFY1 WDR36 HDAC6 RTCB POLE WDR70 RRP15 AMBRA1 PTPN23 CHD7 AARSD1 FXR1 SF3B1 CCT5 MAP4K5 TLN1 GEMIN4 MACF1 EXOC1 WDFY3 FSCN1 PCBP1 ATP2A2 XPOT	7.66e-10	1353	343	40	29467282
Pubmed	JAK2 is required for induction of the murine DUB-1 gene.	USP17L7 USP17L1 JAK2 USP17L3 USP17L4 USP17L10 USP17L8	1.28e-09	22	343	7	9154835
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	DLGAP1 APC2 ACTB EDC4 MDN1 ZNF394 AP1B1 MAGED2 NAV1 TLN2 SPATS2 PRRC2A KPNB1 TLK2 RANBP2 MIA3 ANKFY1 NBEA CHD7 KANK2 FXR1 SF3B1 SPHKAP MACF1 APPL1 ELAVL4 WDFY3 SLC4A4 FSCN1 PCBP1 PCNT PROX1	2.76e-09	963	343	32	28671696
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	DLGAP1 PDE4D SPTA1 ACTB ACTG1 SPIRE1 EDC4 HSPA12A AP1B1 SLC24A2 NAV1 TLN2 MICAL3 PRRC2A KPNB1 FLNC ASRGL1 VWF RTCB TNC NBEA AP3B1 KANK2 SLC6A1 NHSL1 PACS1 FXR1 SF3B1 CCT5 PEBP1 TLN1 MACF1 EXOC1 PEAK1 SLC4A4 FSCN1 MAP2K1 PCBP1 ATP2A2 PBXIP1	3.75e-09	1431	343	40	37142655
Pubmed	Identification of a novel actin isoform in hepatocellular carcinoma.	ACTB ACTG1 POTEKP POTEE POTEF POTEI	4.09e-09	15	343	6	16824795
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ZNF623 TSC22D1 FAT2 TTBK1 MICAL3 EXOC7 KLHL18 MED12 PRUNE2 SYNM PTPN23 ZNF407 PNKD KHDC4 PPP4R4 MACF1 APPL1 ANKRD24 FHDC1 PEAK1 MORC3 UNC80	5.47e-09	493	343	22	15368895
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	DLGAP1 CSMD2 RYR1 MEPE JAK2 BRCA2 PLCG1 FLNC HDAC6 GRB10 NBEA PEBP1 MAP4K5 APOL5 LRP2 LRBA FYB1 ATP2A3	6.20e-09	329	343	18	17474147
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	SPART GON4L CMYA5 RYR1 SUPT6H COL14A1 ACAA2 MED13 KPNB1 COL6A3 FLNC RANBP2 ANKFY1 VWF CDC42BPA ZNF407 CLIP4 TLN1 C1QTNF9 MACF1 APPL1 EXOC1	6.33e-09	497	343	22	23414517
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	ZNF143 NCLN CSMD2 RYR1 MEPE MDN1 SFTPA2 AP1B1 HFM1 ANKFY1 TNC POLE NBEA CHD7 MED1 AP3B1 PIAS1 PPP4R4 ARID3B KMT2D TRAPPC12 BBS7 WDFY3 MAP2K2 CDH17	6.69e-09	638	343	25	31182584
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	ACTB EDC4 MDN1 AP1B1 MAGED2 SUPT6H FOXK1 KPNB1 RANBP2 ANKFY1 DSG2 PTPN23 AP3B1 FXR1 SF3B1 CCT5 TLN1 GEMIN4 APPL1 LRBA MAP2K2 PCBP1 ATP2A2 XPOT SYMPK	6.69e-09	638	343	25	33239621
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	SETD1A ACTG1 EDC4 TRRAP BRD8 PTPN13 PRRC2A MED12 KPNB1 DSG2 RTCB PTPN23 MED1 AP3B1 ARID3B KMT2D CCT5 TLN1 TET1 LRBA PEAK1 PCBP1 SYMPK	7.98e-09	549	343	23	38280479
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	ACTB ACTG1 SORT1 PHKA1 HSPA12A PTPN13 PEX19 CPSF1 ALDH18A1 MICAL3 HERC1 PRRC2A FOXC1 KPNB1 RANBP2 MIA3 CDC42BPA VEZT PTPN23 NBEA AP3B1 PPP4R4 NHSL1 PACS1 KMT2D CCT5 TMF1 PEAK1 ATP2A2 XPOT PCNT SYMPK	2.07e-08	1049	343	32	27880917
Pubmed	High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency.	USP17L7 USP17L1 USP17L3 USP17L4 USP17L8	2.19e-08	10	343	5	24207026
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	ACTG1 SPART BRCA2 PIGR MAGED2 CEP97 FOXK1 TLK2 FLNC RANBP2 SUPT20H WDR70 MED1 PIAS1 ARID3B FXR1 SF3B1 TLN1 PCBP1 SYMPK	2.35e-08	444	343	20	34795231
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	DLGAP1 ERBB4 EDC4 NCLN LRP1B MET HSPA12A BTF3 PEX19 NAV1 TLN2 RANBP2 MIA3 ASRGL1 CDC42BPA VEZT NBEA ATL1 SLC6A1 ARFGEF3 NHSL1 SF3B1 CCT5 PEBP1 SPHKAP CNTNAP2 MACF1 APPL1 ELAVL4 EXOC1 PEAK1 SLC4A4 ATP2A2	4.16e-08	1139	343	33	36417873
Pubmed	DUB-1, a deubiquitinating enzyme with growth-suppressing activity.	USP17L7 USP17L1 USP17L3 USP17L4 USP17L10 USP17L8	4.22e-08	21	343	6	8622927
Pubmed	DUB-1A, a novel deubiquitinating enzyme subfamily member, is polyubiquitinated and cytokine-inducible in B-lymphocytes.	USP17L7 USP17L1 USP17L3 USP17L4 USP17L10 USP17L8	4.22e-08	21	343	6	14583620
Pubmed	DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes.	USP17L7 USP17L1 USP17L3 USP17L4 USP17L10 USP17L8	4.22e-08	21	343	6	11468161
Pubmed	The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor.	USP17L7 USP17L1 USP17L3 USP17L4 USP17L10 USP17L8	4.22e-08	21	343	6	8756639
Pubmed	Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines.	USP17L7 USP17L1 USP17L3 USP17L4 USP17L10 USP17L8	4.22e-08	21	343	6	12447969
Pubmed	DUB-1, a fate determinant of dynein heavy chain in B-lymphocytes, is regulated by the ubiquitin-proteasome pathway.	USP17L7 USP17L1 USP17L3 USP17L4 USP17L10 USP17L8	4.22e-08	21	343	6	18980247
Pubmed	DDB1 binds histone reader BRWD3 to activate the transcriptional cascade in adipogenesis and promote onset of obesity.	SETD1A DDB2 MED24 SUPT6H MED12 WDR36 HDAC6 WDR70 MED1 WDFY3	5.47e-08	99	343	10	34161765
Pubmed	Cell cycle-dependent expression of Dub3, Nanog and the p160 family of nuclear receptor coactivators (NCoAs) in mouse embryonic stem cells.	USP17L7 USP17L1 USP17L3 USP17L4 USP17L8	6.78e-08	12	343	5	24695638
Pubmed	DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes.	USP17L7 USP17L1 USP17L3 USP17L4 USP17L10 USP17L8	1.02e-07	24	343	6	8995226
Pubmed	A human MAP kinase interactome.	DLGAP1 PAK6 TSC22D1 NAV1 CPLANE1 FLNC RANBP2 VWF SUPT20H CDC42BPA PTPN23 PIAS1 SF3B1 MAP4K5 MACF1 YY1AP1 ANKRD24 SLC4A4 MAP2K1 MAP2K2	1.02e-07	486	343	20	20936779
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	MAN2A1 ACP3 RYR1 HSPA12A FAT1 PTPN13 EML5 PIGR PKHD1 PRRC2A KPNB1 NPC1 COL6A3 ANKFY1 VWF CDC42BPA NRF1 VPS50 PTPN23 CCT5 PEBP1 ASL TLN1 GEMIN4 LRP2 ABCB11 APPL1 SLC4A4 SLC26A11 PCBP1	1.18e-07	1016	343	30	19056867
Pubmed	Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production.	USP17L7 USP17L1 USP17L3 USP17L4 USP17L10 USP17L8	1.33e-07	25	343	6	21115691
Pubmed	The testis-specific VAD1.3/AEP1 interacts with β-actin and syntaxin 1 and directs peri-nuclear/Golgi expression with bipartite nucleus localization (BNL) sequence.	SPATA31A7 SPATA31A3 SPATA31A5 SPATA31A1	1.37e-07	6	343	4	20850414
Pubmed	Targeted disruption of the spermatid-specific gene Spata31 causes male infertility.	SPATA31A7 SPATA31A3 SPATA31A5 SPATA31A1	1.37e-07	6	343	4	25930072
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ERBB4 SPIRE1 PAK6 EDC4 PTPN13 MDN1 NAV1 FOXK1 CDC42BPA DSG2 RTCB POTEF GRB10 FRYL RGS12 PPP4R4 ARFGEF3 NHSL1 FXR1 TET1 MACF1 AKAP11 PEAK1 MORC3 MAP2K1 MAP2K2 SAMD4A	1.61e-07	861	343	27	36931259
Pubmed	ES cell neural differentiation reveals a substantial number of novel ESTs.	USP17L7 USP17L1 USP17L3 USP17L4 USP17L8	1.69e-07	14	343	5	11793228
Pubmed	Decabromodiphenyl ethane affects embryonic development by interfering with nuclear F-actin in zygotes and leads to cognitive and social disorders in offspring mice.	USP17L7 USP17L1 USP17L3 USP17L4 USP17L10 USP17L8	1.72e-07	26	343	6	35816173
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	EDC4 PTPN13 MAGED2 BTF3 MICAL3 CEP97 MIA3 KANK2 ARFGEF3 NHSL1 MACF1 AKAP11 PEAK1	1.87e-07	209	343	13	36779422
Pubmed	Cooperative activity of cdk8 and GCN5L within Mediator directs tandem phosphoacetylation of histone H3.	TRRAP MED24 MED12 MED13 MED1	2.51e-07	15	343	5	18418385
Pubmed	Minor Splicing Factors Zrsr1 and Zrsr2 Are Essential for Early Embryo Development and 2-Cell-Like Conversion.	USP17L7 USP17L1 USP17L3 USP17L4 USP17L10 USP17L8	3.46e-07	29	343	6	32527007
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	DLGAP1 SPTA1 APC2 PTPN13 AP1B1 ACAN GLRB SPATS2 FAHD2B TNC FAHD2A FXR1 MYO1F MACF1 ELAVL4 MAP2K1 PCBP1 PBXIP1	3.50e-07	430	343	18	32581705
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	DSCAML1 TLN2 PRUNE2 ANKFY1 PTPN23 CHD7 TLN1 MACF1 APPL1 AKAP11 WDFY3 UNC80 PCNT	4.37e-07	225	343	13	12168954
Pubmed	DNA sequence and analysis of human chromosome 8.	USP17L7 USP17L1 USP17L3 COL14A1 USP17L4 CSMD1 USP17L8	4.44e-07	48	343	7	16421571
Pubmed	A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.	SPIRE1 PTPN13 EML5 NAV1 PRRC2A FOXC1 FLNC RANBP2 WDR36 RTCB POLE AMBRA1 SF3B1	6.18e-07	232	343	13	25515538
Pubmed	Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death.	RYR1 RYR3 ATP2A2 ATP2A3	6.31e-07	8	343	4	19033399
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	NCLN TRRAP RYR3 FBXO22 MDN1 AGA NBEAL2 CPSF1 MICAL3 HERC1 MED12 SUPT20H VPS50 NBEA RGS12 CCT5 LRBA ATP2A3 XPOT	6.52e-07	497	343	19	36774506
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	ZNF143 ACTG1 EDC4 TRRAP MED24 AP1B1 BTF3 PRRC2A MED12 FOXK1 KPNB1 TLK2 RANBP2 RTCB CHD7 RUNX2 MED1 KHDC4 PIAS1 PALB2 ARID3B CCDC7 KMT2D CCT5 PEBP1 FRG1 TLN1 TAF5L ATP2A2 XPOT	6.64e-07	1103	343	30	34189442
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	GON4L FAT2 MDN1 HERC1 CDC42BPA FAT3 TEX15 KMT2D FXR1 SF3B1 ZNF335 MACF1 LRBA	6.81e-07	234	343	13	36243803
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	SPART PTPN13 MAGED2 ALDH18A1 MICAL3 PRRC2A MED12 KPNB1 RANBP2 CDC42BPA HDAC6 DSG2 PTPN23 AP3B1 CCT5 MAP4K5 TLN1 GEMIN4 MACF1 LRBA PEAK1 PCBP1 ATP2A2	7.48e-07	708	343	23	39231216
Pubmed	Cdc25A and Dub3 in a high-stakes balancing act.	USP17L7 USP17L1 USP17L3 USP17L4 USP17L10 USP17L8	7.79e-07	33	343	6	20228807
Pubmed	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.	MAN2A1 SPIRE1 SORT1 JAK2 MED24 MET FAT1 STX4 MDN1 ATP11C HERC1 PLXNA1 RTCB VEZT ROR1 POMT1 PNKD FXR1 TMF1 IPO13 MACF1 WDFY3 LRBA SLC4A4 FSCN1 ATP2A3 CDH17 XPOT SYMPK	9.31e-07	1061	343	29	33845483
Pubmed	DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation.	USP17L7 USP17L1 USP17L3 USP17L4 USP17L10 USP17L8	9.38e-07	34	343	6	14699124
Pubmed	The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence.	USP17L7 USP17L1 USP17L3 USP17L4 USP17L10 USP17L8	9.38e-07	34	343	6	15780755
Pubmed	Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability.	USP17L7 USP17L1 USP17L3 USP17L4 USP17L10 USP17L8	9.38e-07	34	343	6	17109758
Pubmed	Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme.	USP17L7 USP17L1 USP17L3 USP17L4 USP17L10 USP17L8	9.38e-07	34	343	6	20715989
Pubmed	Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation.	USP17L7 USP17L1 USP17L3 USP17L4 USP17L10 USP17L8	9.38e-07	34	343	6	9806828
Pubmed	The DUB/USP17 deubiquitinating enzymes: a gene family within a tandemly repeated sequence, is also embedded within the copy number variable beta-defensin cluster.	USP17L7 USP17L1 USP17L3 USP17L4 USP17L10 USP17L8	9.38e-07	34	343	6	20403174
Pubmed	USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity.	USP17L7 USP17L1 USP17L3 USP17L4 USP17L10 USP17L8	9.38e-07	34	343	6	19188362
Pubmed	Unstable transmission of the RS447 human megasatellite tandem repetitive sequence that contains the USP17 deubiquitinating enzyme gene.	USP17L7 USP17L1 USP17L3 USP17L4 USP17L10 USP17L8	9.38e-07	34	343	6	11941478
Pubmed	The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression.	USP17L7 USP17L1 USP17L3 USP17L4 USP17L10 USP17L8	9.38e-07	34	343	6	20388806
Pubmed	The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling.	USP17L7 USP17L1 USP17L3 USP17L4 USP17L10 USP17L8	9.38e-07	34	343	6	20368735
Pubmed	The RS447 human megasatellite tandem repetitive sequence encodes a novel deubiquitinating enzyme with a functional promoter.	USP17L7 USP17L1 USP17L3 USP17L4 USP17L10 USP17L8	9.38e-07	34	343	6	10936051
Pubmed	The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility.	USP17L7 USP17L1 USP17L3 USP17L4 USP17L10 USP17L8	9.38e-07	34	343	6	21448158
Pubmed	CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1.	USP17L7 USP17L1 USP17L3 USP17L4 USP17L8	9.41e-07	19	343	5	28067227
Pubmed	Small GTPase RBJ mediates nuclear entrapment of MEK1/MEK2 in tumor progression.	DNAJC27 MAP2K1 MAP2K2	9.51e-07	3	343	3	24746703
Pubmed	Taking the next step forward - Diagnosing inherited infantile cholestatic disorders with next generation sequencing.	PKHD1 NPC1 ABCB11	9.51e-07	3	343	3	25771912
Pubmed	Identification and Characterization of K(+)-Dependent Na(+)-Ca(2+) Exchange Transport in Pigmented MEB4 Cells Mediated by NCKX4.	SLC24A5 SLC24A4 SLC24A2	9.51e-07	3	343	3	27093457
Pubmed	Comparative genomics and diversifying selection of the clustered vertebrate protocadherin genes.	FAT1 FAT2 FAT3	9.51e-07	3	343	3	15744052
Pubmed	CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI.	NCLN TRRAP PTPN13 MDN1 MAGED2 MICAL3 PRRC2A ARFGEF3 XPOT	9.60e-07	104	343	9	31240132
Pubmed	Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways.	PDE4D ACTB ACTG1 SORT1 PTPN13 CC2D2A ACAA2 CPLANE1 CEP97 KPNB1 FLNC GRB10 PEBP1 CNTNAP2 GEMIN4 EXOC1 FSCN1 PCBP1 ATP2A2 XPOT	1.06e-06	564	343	20	21565611
Pubmed	Cytokine-regulated protein degradation by the ubiquitination system.	USP17L7 USP17L1 USP17L3 USP17L4 USP17L10 USP17L8	1.12e-06	35	343	6	16611142
Pubmed	Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity.	USP17L7 USP17L1 USP17L3 USP17L4 USP17L10 USP17L8	1.12e-06	35	343	6	21239494
Pubmed	Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex.	MED24 MED12 MED13 MED1	1.13e-06	9	343	4	8710870
Pubmed	The nuclear interactome of DYRK1A reveals a functional role in DNA damage repair.	ERCC5 ABRAXAS1 PEX19 SUPT20H WDR70 AP3B1 AARSD1 KMT2D LRBA	1.13e-06	106	343	9	31024071
Pubmed	The deubiquitinating enzyme USP17 blocks N-Ras membrane trafficking and activation but leaves K-Ras unaffected.	USP17L7 USP17L1 USP17L3 USP17L4 USP17L10 USP17L8	1.34e-06	36	343	6	20147298
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	USP17L7 OR13C8 NEXMIF CSMD2 DSCAML1 RYR1 ESRP2 JAK2 POTEE MDN1 PKHD1 USP17L3 CPSF1 ALDH18A1 ROR1 WNT2B PCDHB12 MUC19 NBEA TLN1 LRP2 SLC26A11 SYMPK	1.44e-06	736	343	23	29676528
Pubmed	Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A.	USP17L7 USP17L1 USP17L3 USP17L4 USP17L10 USP17L8	1.58e-06	37	343	6	20228808
Pubmed	A coregulatory role for the TRAP-mediator complex in androgen receptor-mediated gene expression.	MED24 MED12 MED13 MED1	1.86e-06	10	343	4	12218053
Pubmed	Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair.	ACTB ACTG1 SPART BRCA2 ALDH18A1 KPNB1 RANBP2 WDR70 PIAS1 ARID3B SF3B1 CCT5 PCBP1 ATP2A2 SYMPK	3.19e-06	357	343	15	37059091
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	MKRN3 PDE4D DSCAML1 GLE1 SUPT6H SDK1 FOXC1 SEMA6C WDR36 HDAC6 CHD7 SF3B1 MACF1 CDH4 PROX1	3.30e-06	358	343	15	32460013
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	ACTB ACTG1 FAT1 TLN2 CPLANE1 DNAH9 PRRC2A ANKFY1 WDR70 KANK2 ARFGEF3 SF3B1 ASL MACF1 PCBP1	3.65e-06	361	343	15	26167880
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	SPART EDC4 SORT1 MED24 AP1B1 MAGED2 SUPT6H ALDH18A1 ACAA2 EXOC7 KPNB1 WDR36 VPS50 AP3B1 ARID3B FXR1 EXOC1 XPOT SYMPK	3.74e-06	560	343	19	35241646
Pubmed	Alpha subunit-dependent glycine receptor clustering and regulation of synaptic receptor numbers.	GLRA1 GLRB GLRA3	3.78e-06	4	343	3	28883437
Pubmed	Activation of glycine receptor phase-shifts the circadian rhythm in neuronal activity in the mouse suprachiasmatic nucleus.	GLRA1 GLRB GLRA3	3.78e-06	4	343	3	21486797
Pubmed	Expression and mRNA splicing of glycine receptor subunits and gephyrin during neuronal differentiation of P19 cells in vitro, studied by RT-PCR and immunocytochemistry.	GLRA1 GLRB GLRA3	3.78e-06	4	343	3	9051263
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	ERCC5 SPIRE1 MED24 BRD8 PTPN13 EML5 AGA PLCG1 HERC1 CPLANE1 NPC1 TLK2 MIA3 HDAC6 PTPN23 FRYL DEPDC1 CHD7 AP3B1 CD160 PACS1 FXR1 TET1 LRP2 MACF1 PEAK1 XPOT PCNT	4.22e-06	1084	343	28	11544199
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	APC2 ACTB ACTG1 POTEKP POTEE ACAN CPSF1 KLHL18 KPNB1 COL6A3 ANKFY1 POTEF PALB2 NLRP14 SF3B1 CCT5 PCBP1 ATP2A3	4.26e-06	513	343	18	25798074
Pubmed	MRG15 is a novel PALB2-interacting factor involved in homologous recombination.	TRRAP BRD8 BRCA2 PALB2	4.32e-06	12	343	4	19553677
Pubmed	POH1 contributes to hyperactivation of TGF-β signaling and facilitates hepatocellular carcinoma metastasis through deubiquitinating TGF-β receptors and caveolin-1.	ACTB ACTG1 CMYA5 SUPT6H PKHD1 HERC1 TMC2 RTCB DEPDC1 KANK2 CCT5 SYTL1 PCNT	4.41e-06	277	343	13	30745168
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	PTPN13 BRCA2 NAV1 MED12 RANBP2 ANKFY1 CHD7 PALB2 KMT2D TET1 GEMIN4 LRP2 TMF1 LRBA PCNT PROX1	4.93e-06	418	343	16	34709266
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	PDE4D ACP3 SPIRE1 TRRAP ITPK1 JAK2 TSC22D1 PTPN13 SUPT6H NAV1 MICAL3 PLCG1 SPATS2 PRUNE2 MIA3 CDC42BPA NRF1 VEZT WDR70 GRB10 ZBTB8A FRYL POMT1 PPP4R4 ARFGEF3 PACS1 MACF1 ANKRD24 LRBA CSMD1 SYTL1 MAP2K2 CDH15 PCNT	5.67e-06	1489	343	34	28611215
Pubmed	Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane.	ABCA3 TNFRSF11A LRP1B MDN1 SPATS2 PRRC2A MIA3 DSG2 VEZT ATL1 FXR1 SF3B1 TLN1 DDRGK1 PBXIP1	5.77e-06	375	343	15	32788342
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	SPTA1 ACTB ZKSCAN8 ACTG1 NCLN TRRAP DDB2 BRD8 MDN1 SUPT6H ABRAXAS1 CPSF1 FOXK1 FOXC1 KPNB1 RANBP2 SUPT20H WDR36 RTCB RRP15 CHD7 MED1 PALB2 KMT2D SF3B1 FRG1 TAF5L PCBP1 ATP2A2 SAMD4A SYMPK	5.84e-06	1294	343	31	30804502
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	ACTG1 EDC4 NCLN CMYA5 MDN1 MAGED2 SUPT6H CPSF1 ALDH18A1 CC2D2A TLN2 PLCG1 PLXNA1 KPNB1 RANBP2 ANKFY1 WDR36 DSG2 RTCB POLE RRP15 AP3B1 FXR1 SF3B1 CCT5 PEBP1 TLN1 GEMIN4 TAF5L PEAK1 PCBP1 ATP2A2 XPOT	5.86e-06	1425	343	33	30948266
Pubmed	Defining the membrane proteome of NK cells.	MAN2A1 ACAA1 ACTB ACTG1 ITGA4 EDC4 NCLN MAN1A2 MDN1 MAGED2 GLE1 NBEAL2 EXOC7 PRRC2A MED12 MED13 KPNB1 NPC1 RANBP2 MIA3 VPS50 MED1 AP3B1 FXR1 GEMIN4 EXOC1 LRBA PCBP1 PCNT	6.04e-06	1168	343	29	19946888
Pubmed	Localization of human cadherin genes to chromosome regions exhibiting cancer-related loss of heterozygosity.	CDH3 CDH6 CDH15 CDH17	6.20e-06	13	343	4	9615235
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	ACAA1 SPTA1 ACTB EDC4 RYR1 MDN1 AP1B1 ALDH18A1 KPNB1 FLNC MIA3 RTCB MUC19 AP3B1 EPG5 CCT5 PEBP1 TLN1 MACF1 LRBA PEAK1 ATP2A2 XPOT	6.57e-06	807	343	23	30575818
Interaction	TOP3B interactions	SETD1A ACTG1 SPIRE1 EDC4 NCLN TRRAP RYR1 ESRP2 JAK2 FAT1 HEG1 FBXO22 STX4 MDN1 NBEAL2 NAV1 CPSF1 TLN2 MICAL3 PLCG1 HERC1 PRRC2A MED12 PLXNA1 MED13 FOXK1 PICK1 NPC1 SEMA6C FLNC CDC42BPA WDR36 NRF1 POLE WDR70 GRB10 AMBRA1 FRYL LRRK1 KANK2 NHSL1 KMT2D FXR1 TRAPPC12 ZNF335 TLN1 DDRGK1 WDFY3 LRBA ATP2A3 PCNT SYMPK TJP3	5.41e-08	1470	332	53	int:TOP3B
Interaction	SUPT3H interactions	EDC4 TRRAP DDB2 BRCA2 MED12 MED13 SUPT20H MED1 TAF5L	6.55e-07	61	332	9	int:SUPT3H
Interaction	PFN1 interactions	TRAF6 ACTB ACTG1 ITGA4 PHKA1 BTF3 NAV1 MICAL3 ACAA2 CEP97 RANBP2 ANKFY1 HDAC6 RTCB NBEA NHSL1 ISG15 PEBP1 TMF1 DDRGK1 MACF1 PEAK1 MAP2K2 PCNT	4.34e-06	509	332	24	int:PFN1
Interaction	YWHAZ interactions	DLGAP1 PDE4D SPTA1 ACTG1 SPIRE1 POTEKP ITGA4 PAK6 PTPN13 BTF3 NBEAL2 NAV1 PRR14L PRRC2A FOXK1 TLK2 CDC42BPA HDAC6 DSG2 POTEF GRB10 FRYL AP3B1 KANK2 PIAS1 RGS12 PPP4R4 ARID3B NHSL1 PACS1 SF3B1 DDRGK1 MACF1 APPL1 AKAP11 WDFY3 PEAK1 MORC3 MAP2K1 MAP2K2 ATP2A2 SAMD4A PCNT	1.45e-05	1319	332	43	int:YWHAZ
Interaction	SIGLECL1 interactions	AP1B1 PEX19 EXOC7 NPC1 DEPDC1 ARFGEF3 GEMIN4 IPO13 GEMIN6 SYMPK	1.78e-05	113	332	10	int:SIGLECL1
Interaction	ABL1 interactions	ERBB4 TRAF6 PDE4D SPTA1 DDB2 JAK2 BRCA2 PLCG1 HERC1 BACE2 CDON ASRGL1 GRB10 LRRK1 MAP4K5	2.80e-05	259	332	15	int:ABL1
GeneFamily	WD repeat domain containing\|BEACH domain containing	NBEAL2 NBEA WDFY3 LRBA	3.56e-06	9	239	4	1230
GeneFamily	Ankyrin repeat domain containing\|POTE ankyrin domain containing	POTEKP POTEE POTEF POTEI	1.94e-05	13	239	4	685
GeneFamily	CD molecules\|Type I classical cadherins	CDH3 CDH4 CDH15	2.24e-05	5	239	3	1185
GeneFamily	Glycine receptors	GLRA1 GLRB GLRA3	2.24e-05	5	239	3	868
GeneFamily	Zinc fingers MYND-type\|A-kinase anchoring proteins	CMYA5 SYNM NBEA SPHKAP AKAP11	3.55e-05	29	239	5	396
GeneFamily	Ankyrin repeat domain containing\|FERM domain containing	FRMD4B JAK2 PTPN13 TLN2 TLN1	5.05e-04	50	239	5	1293
GeneFamily	Ryanodine receptors\|Protein phosphatase 1 regulatory subunits	RYR1 RYR3	5.18e-04	3	239	2	287
GeneFamily	WD repeat domain containing	DDB2 EML5 NBEAL2 HERC1 WDR36 WDR70 AMBRA1 NBEA TAF5L WDFY3 LRBA	7.58e-04	262	239	11	362
GeneFamily	Cyclins\|Mediator complex	MED24 MED12 MED13 MED1	9.02e-04	33	239	4	1061
GeneFamily	Cadherin related	FAT1 FAT2 FAT3	1.35e-03	17	239	3	24
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	FSTL5 DSCAML1 ALPK3 SDK1 CDON SIGLEC12 ROR1 HMCN1	1.38e-03	161	239	8	593
GeneFamily	Armadillo repeat containing\|Importins	KPNA7 KPNB1 IPO13	1.61e-03	18	239	3	596
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	APC2 KPNA7 KPNB1 ARMCX5	2.45e-03	43	239	4	409
GeneFamily	Actins	ACTB ACTG1	2.52e-03	6	239	2	929
GeneFamily	Gemins	GEMIN4 GEMIN6	2.52e-03	6	239	2	1131
GeneFamily	Mitogen-activated protein kinase kinases	MAP2K1 MAP2K2	3.50e-03	7	239	2	653
GeneFamily	Guanylate cyclase receptors	NPR2 GUCY2F	3.50e-03	7	239	2	343
GeneFamily	WD repeat domain containing\|Xeroderma pigmentosum complementation groups\|Nucleotide excision repair	ERCC5 DDB2	4.62e-03	8	239	2	1125
GeneFamily	Cytochrome P450 family 3	CYP3A5 CYP3A43	4.62e-03	8	239	2	1002
GeneFamily	Fibronectin type III domain containing	CMYA5 DSCAML1 COL14A1 SDK1 CDON TNC EPHB1	5.46e-03	160	239	7	555
GeneFamily	ATPases Ca2+ transporting	ATP2A2 ATP2A3	5.89e-03	9	239	2	1209
GeneFamily	Exocyst complex	EXOC7 EXOC1	5.89e-03	9	239	2	1055
Coexpression	GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS	MAN2A1 ACTB ACTG1 IER5 MET FAT1 BRD8 MAN1A2 AP1B1 BRCA2 MAGED2 NAV1 GMPR PLCG1 SPATS2 SDK1 CEP97 PLXNA1 FOXK1 CDON PRUNE2 GRB10 RRP15 CHD7 KANK2 ZXDB PACS1 CCT5 PEBP1 FRG1 APPL1 HACL1 WDFY3 FSCN1 ATP2A2 CDH4 SAMD4A PROX1	4.59e-09	1009	340	38	M157
Coexpression	GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN	ACTB ACTG1 MET FAT1 AP1B1 MAGED2 NAV1 PLCG1 SPATS2 SDK1 FOXK1 CDON PRUNE2 RRP15 ZXDB PACS1 APPL1 HACL1 WDFY3 FSCN1 ATP2A2 CDH4 PROX1	1.78e-08	438	340	23	M227
Coexpression	HALLMARK_APICAL_JUNCTION	ACTB ACTG1 STX4 PLCG1 FLNC VWF ADAMTS5 FSCN1 FYB1 CDH3 CDH4 CDH6 CDH15 SYMPK	3.94e-07	200	340	14	M5915
Coexpression	GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP	TRRAP MEPE SUPT6H CPSF1 PRRC2A MED12 MIA3 AMBRA1 POMT1 PIAS1 OR1D2 TLN1 GEMIN4	2.22e-06	199	340	13	M7254
Coexpression	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN	MKRN3 OR13C8 SPATA31A7 SPIRE1 POTEKP ADCYAP1R1 MEPE POTEE FAT2 SLC24A4 UGT2B10 NAV1 SDK1 CNGA3 ZNF438 WDR36 SPATA31A3 ZBTB8A AMBRA1 LRRK1 ZXDB CCDC7 ADGB TET1 MAP2K1 FYB1 BBS12 CDH4	1.17e-05	873	340	28	M16009
Coexpression	GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN	SETD1A EDC4 CPSF1 ATP11C ACAA2 HERC1 MED12 MED13 MIA3 PGGHG ARMCX5 PACS1	1.23e-05	199	340	12	M9501
Coexpression	GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_UP	ERCC5 JAK2 SUPT6H MICB SDC4 PLXNA1 TLN1 MYO1F MACF1 FSCN1 MAP2K2 ATP2A2	1.23e-05	199	340	12	M9964
Coexpression	LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2	DLGAP1 PDE4D PKHD1 UGT2B7 SDK1 PRUNE2 NBEA LRP2 WDFY3 CDH6 SAMD4A	2.03e-05	176	340	11	M39223
Coexpression	GRYDER_PAX3FOXO1_TOP_ENHANCERS	ACTB ACTG1 IER5 FAT1 MAN1A2 AP1B1 BRCA2 MAGED2 GMPR CDON GRB10 CHD7 PEBP1 APPL1 HACL1 FSCN1 SAMD4A PROX1	2.13e-05	441	340	18	M172
Coexpression	BUSSLINGER_DUODENAL_LATE_IMMATURE_ENTEROCYTES	CYP2C18 ACAA1 CYP3A5 PIGR UGT2B7 ACAA2 XDH PEBP1 HACL1 SLC4A4 CDH17	2.14e-05	177	340	11	M40028
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	RELN ABCA3 PDE4D APC2 NUTM2A CSMD2 LRP1B DSCAML1 FRMD4B HSPA12A FAT2 MDN1 SLC24A2 NAV1 TLN2 MICAL3 HERC1 PLXNA1 CDON MIA3 MUC19 NBEA ATL1 SLC6A1 ARFGEF3 PACS1 CNTNAP2 ELAVL4 CSMD1 CDH4 GPR176 EPHB1	2.16e-05	1106	340	32	M39071
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	MAN2A1 SPART TRRAP FAT1 HEG1 PTPN13 MDN1 BRCA2 GLRB MICAL3 MED13 TLK2 RANBP2 SUPT20H CDC42BPA ROR1 FRYL MED1 AP3B1 FXR1 MAP4K5 MACF1 AKAP11 WDFY3 MAP2K1 SAMD4A PCNT	2.25e-05	856	340	27	M4500
Coexpression	GSE13493_CD4INTCD8POS_VS_CD8POS_THYMOCYTE_DN	SPART LRP1B SLC24A2 KLHL18 MED12 SLC4A4 SYTL1 QTRT1 MAP2K2 SLC26A11 SYMPK	5.98e-05	198	340	11	M3317
Coexpression	GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_1H_DN	CD52 ACAA1 EDC4 ITPK1 SORT1 JAK2 MICB RNF34 ADAMTS5 MYO1F FYB1	6.26e-05	199	340	11	M9913
Coexpression	GSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_DN	SPTA1 TSC22D1 HEG1 BRCA2 MICB GMPR NPC1 TLK2 RTCB ISG15 SAMD4A	6.26e-05	199	340	11	M6837
Coexpression	GSE40273_XBP1_KO_VS_WT_TREG_DN	ABCA3 ITGA4 TRRAP NBEAL2 HERC1 CDON CHD7 LRRK1 MYO1F FSCN1 CDH17	6.26e-05	199	340	11	M9124
Coexpression	GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_1H_DN	WDR70 NBEA KHDC4 CD160 SLC6A1 PEBP1 CNTNAP2 LRP2 BPIFB2 PCBP1 BBS12	6.55e-05	200	340	11	M9935
Coexpression	GSE17721_POLYIC_VS_CPG_4H_BMDC_DN	MAN2A1 IER5 DSCAML1 STX4 SDC4 SLC34A2 RRP15 MAP4K5 FSCN1 ATP2A3 CDH6	6.55e-05	200	340	11	M3942
Coexpression	HUI_MAPK14_TARGETS_UP	PAK6 PKHD1L1 ISG15 CNTNAP2	9.24e-05	19	340	4	M1289
Coexpression	GSE3920_IFNA_VS_IFNG_TREATED_FIBROBLAST_UP	ITGA4 PTPN13 NOD1 NBEAL2 ASRGL1 FRYL LRRK1 SLC28A2 LRBA ATP2A3	1.02e-04	175	340	10	M6690
Coexpression	LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM	PDE4D CYP3A5 GON4L CSMD2 FRMD4B MET MDN1 TLN2 CDON PRUNE2 CNTNAP2 SLC28A1 LRP2 CSMD1 SLC4A4 ATP2A2	1.25e-04	417	340	16	M39224
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	PRR14L HERC1 KLHL18 MED13 POLE FRYL CHD7 TLN1 MACF1 ATP2A2	1.29e-04	180	340	10	M8239
Coexpression	MADAN_DPPA4_TARGETS	USP17L7 USP17L1 USP17L3 USP17L4 USP17L10 MYO1F USP17L8	1.30e-04	86	340	7	MM1312
Coexpression	HUI_MAPK14_TARGETS_UP	PAK6 PKHD1L1 ISG15 CNTNAP2	1.40e-04	21	340	4	MM543
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000	MKRN3 FSTL5 ZKSCAN8 IER5 ITGA4 RYR3 MAN1A2 EML5 GLRB COL14A1 ATP11C CPLANE1 MED13 KPNB1 VEZT TNC FAT3 ROR1 PCDHB12 PCDHB3 ADAMTS5 PIAS1 CLIP4 MAP4K5 APPL1 ELAVL4 SLC4A4 CDH6	5.60e-05	818	322	28	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000
CoexpressionAtlas	ratio_induced-DefinitiveEndoderm_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#2	RELN BDKRB2 HEG1 FOXC1 FLNC VWF SYNM TNC ADAMTS5 PKHD1L1 CLIP4	5.97e-05	170	322	11	ratio_DE_vs_SC_500_K2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_1000	MKRN3 PDE4D GPR50 ZKSCAN8 IER5 ITGA4 GLRB COL14A1 ATP11C BACE2 CPLANE1 FOXK1 KPNB1 ASRGL1 ZNF560 VEZT PCDHB12 PCDHB3 DEPDC1 PIAS1 FXR1 MAP4K5 SPHKAP APPL1 ELAVL4 GPR176 SAMD4A EPHB1	6.62e-05	826	322	28	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	SPIRE1 ADCYAP1R1 BRD8 EML5 BRCA2 ABRAXAS1 ATP11C MICAL3 ITIH6 KPNB1 RANBP2 POLE CHD7 PIAS1 PALB2 FXR1 CEP83 TMF1 BBS12 CDH4 PCNT	6.93e-05	532	322	21	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000	NEXMIF FRMD4B ADCYAP1R1 HEG1 PTPN13 MAGED2 CC2D2A ACAA2 BACE2 CDON NPC1 COL6A3 FLNC NPR2 FAT3 WNT2B RNF34 TEX15 KCNG3 AARSD1 PPP4R4 PLA2R1 HMCN1 PEAK1 SLC4A4 CDH3 CDH6	9.04e-05	797	322	27	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#1_top-relative-expression-ranked_1000	MKRN3 GPR50 IER5 ITGA4 GLRB FOXK1 ZNF560 PCDHB12 PCDHB3 DEPDC1 PIAS1 FXR1 MAP4K5 APPL1 ELAVL4 GPR176	9.38e-05	349	322	16	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k1_1000
CoexpressionAtlas	alpha beta T cells, T.8Eff.Sp.OT1.d8.VSVOva, CD8+ CD45.1+, Spleen, avg-3	MAN2A1 ITGA4 PAK6 PTPN13 NOD1 NBEAL2 CARD6 PLCG1 CYSLTR2 FRYL CHD7 RUNX2 CD160 MYO1F SLC28A2 MACF1 PEAK1	9.59e-05	387	322	17	GSM538392_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000	CD52 NEXMIF ACP3 APC2 PAK6 SORT1 ESRP2 MET EML5 GLRB NAV1 COL14A1 SDK1 CEP97 PLXNA1 CDON COL6A3 VWF DSG2 TNC CHD7 TEX15 ARID3B PLA2R1 NR2E1 LRP2 MACF1 ELAVL4 PEAK1 FYB1 CDH3	1.03e-04	984	322	31	Facebase_RNAseq_e10.5_Olfactory Pit_1000
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN SPTA1 LRP1B DSCAML1 RYR3 FAT1 SLC24A2 PKHD1 TLN2 DNAH9 SDK1 FAT3 PKHD1L1 ARFGEF3 HMCN1 GUCY2F LRP2 ELAVL4 CSMD1 SLC4A4 UNC80	1.21e-18	184	342	21	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN SPTA1 LRP1B DSCAML1 RYR3 FAT1 SLC24A2 PKHD1 TLN2 DNAH9 SDK1 FAT3 PKHD1L1 ARFGEF3 HMCN1 GUCY2F LRP2 ELAVL4 CSMD1 SLC4A4 UNC80	1.21e-18	184	342	21	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN SPTA1 LRP1B DSCAML1 RYR3 FAT1 SLC24A2 PKHD1 TLN2 DNAH9 SDK1 FAT3 PKHD1L1 ARFGEF3 HMCN1 GUCY2F LRP2 ELAVL4 CSMD1 SLC4A4 UNC80	1.21e-18	184	342	21	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	COVID-19-kidney-Epi_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DLGAP1 RELN ERBB4 CYP3A5 OR13C4 DSCAML1 MET HSPA12A FAT1 PKHD1 UGT2B7 MICAL3 SDK1 PRUNE2 LRP2 CDH6 GPR176	4.85e-14	178	342	17	544379f5a6145429762258d426b876bb36c112f5
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D231\|Adult / Lineage, Cell type, age group and donor	DLGAP1 ERBB4 ABCA3 PDE4D MET PTPN13 SFTPA2 PIGR SFTPA1 ADGRF1 SDC4 SLC34A2 ARFGEF3 LRP2 FHDC1 SLC4A4	1.76e-12	189	342	16	dab54a52358f66a8a9460cd6089a06c5fa7e7a5d
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRP1B DSCAML1 RYR3 PKHD1 DNAH9 FAT3 GLRA3 MUC19 PKHD1L1 CCDC7 HMCN1 SPHKAP CNTNAP2 LRP2 UNC80	2.00e-12	160	342	15	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRP1B DSCAML1 RYR3 PKHD1 DNAH9 FAT3 GLRA3 MUC19 PKHD1L1 CCDC7 HMCN1 SPHKAP CNTNAP2 LRP2 UNC80	2.00e-12	160	342	15	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2\|Adult / Lineage, Cell type, age group and donor	ERBB4 ABCA3 PDE4D FRMD4B MET PTPN13 SFTPA2 SFTPA1 ADGRF1 SDC4 SLC34A2 PPP4R4 ARFGEF3 LRP2 FHDC1 SLC4A4	2.43e-12	193	342	16	738f4f0a9ddde2432b429ab46838e353b1790589
ToppCell	Control-Epithelial_cells-AT2\|Control / group, cell type (main and fine annotations)	DLGAP1 ERBB4 ABCA3 PDE4D SPIRE1 FRMD4B PTPN13 SFTPA2 SFTPA1 SLC34A2 PPP4R4 ARFGEF3 LRP2 FHDC1 SLC4A4	1.10e-11	180	342	15	198b19e7910b4a8cc7e820c525ab357c7f99f578
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ERBB4 ABCA3 PDE4D SPIRE1 FRMD4B MET PTPN13 SFTPA2 SFTPA1 SLC34A2 PPP4R4 ARFGEF3 LRP2 FHDC1 SLC4A4	2.99e-11	193	342	15	f3cc7cfdbc164a4ed42f87647111522b7d393bcb
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ERBB4 ABCA3 PDE4D SPIRE1 FRMD4B MET PTPN13 SFTPA2 SFTPA1 SLC34A2 PPP4R4 ARFGEF3 LRP2 FHDC1 SLC4A4	2.99e-11	193	342	15	fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CSMD2 LRP1B ADCYAP1R1 RYR3 TTBK1 COL14A1 ITIH6 DNAH9 CDON FAT3 MUC19 HMCN1 WDFY3 CSMD1 UNC80	3.46e-11	195	342	15	19853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CSMD2 LRP1B ADCYAP1R1 RYR3 TTBK1 COL14A1 ITIH6 DNAH9 CDON FAT3 MUC19 HMCN1 WDFY3 CSMD1 UNC80	3.46e-11	195	342	15	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ERBB4 ABCA3 SPIRE1 FRMD4B MET PTPN13 SFTPA2 SFTPA1 SDC4 NPC1 SLC34A2 ARFGEF3 LRP2 FHDC1 SLC4A4	4.30e-11	198	342	15	2e2a4e1756bba6f4fbe529559a97d2993c890b4b
ToppCell	COVID-19-Epithelial_cells-AT2\|COVID-19 / group, cell type (main and fine annotations)	DLGAP1 ERBB4 ABCA3 PDE4D MET PTPN13 SFTPA2 PIGR SFTPA1 ADGRF1 SDC4 SLC34A2 ARFGEF3 LRP2	1.82e-10	184	342	14	369b82f793deab672204558ae4e112cfa5aa9ccc
ToppCell	COVID-19-kidney-PCT-S2\|kidney / Disease (COVID-19 only), tissue and cell type	DLGAP1 CYP3A5 DSCAML1 FAT1 PKHD1 UGT2B7 SDK1 PRUNE2 ROR1 SLC28A1 LRP2 SLC4A4 CDH6 SAMD4A	2.59e-10	189	342	14	0be5c669b6b308bd98ddb70c84877c62a6244bbd
ToppCell	COVID-19-lung-AT2\|lung / Disease (COVID-19 only), tissue and cell type	ERBB4 ABCA3 PDE4D MET PTPN13 SFTPA2 SFTPA1 ADGRF1 SDC4 SLC34A2 ARFGEF3 LRP2 FHDC1 SLC4A4	2.98e-10	191	342	14	276455a64c2c3503d5048615762eb2ee37f0ac70
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN SLC24A2 GMPR HERC1 BACE2 MIA3 HDAC6 NBEA FRYL SPHKAP MACF1 ATP2A2 ATP2A3 UNC80	3.91e-10	195	342	14	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN SLC24A2 GMPR HERC1 BACE2 MIA3 HDAC6 NBEA FRYL SPHKAP MACF1 ATP2A2 ATP2A3 UNC80	3.91e-10	195	342	14	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	COVID-19-kidney-Distal_Epi_Doublet_(PCT)\|kidney / Disease (COVID-19 only), tissue and cell type	ERBB4 LRP1B MET PKHD1 UGT2B7 TLN2 SDK1 PRUNE2 ROR1 SLC28A1 LRP2 SLC4A4 CDH6	1.18e-09	176	342	13	36f77d878a53b30465b0dea8333a3865dba75613
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CYP3A5 DSCAML1 MET FAT1 PKHD1 UGT2B7 MICAL3 SDK1 PRUNE2 SLC28A1 LRP2 CDH6 SAMD4A	2.31e-09	186	342	13	f28d72b47624b69a580b4429e2be560a26898591
ToppCell	facs-Aorta-Heart-3m-Mesenchymal\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MET FAT1 PTPN13 COL14A1 SDC4 CDON FLNC DSG2 ROR1 NR1D1 CLIP4 CDH3 PBXIP1	3.40e-09	192	342	13	0dc1f46e40346ed0b286e53b106a812441575100
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DLGAP1 ERBB4 PDE4D CMYA5 MET FAT1 PKHD1 UGT2B7 MICAL3 SDK1 PRUNE2 LRP2 CDH6	3.85e-09	194	342	13	7002937e8903e037332a215d00fbc7c7843b33f2
ToppCell	ASK440-Epithelial-Type_2\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	ABCA3 PDE4D MET TSC22D1 PTPN13 SFTPA2 PIGR SFTPA1 SDC4 SLC34A2 ARFGEF3 NHSL1 FHDC1	4.36e-09	196	342	13	754b4202b617165c6994a0b5a9b1e486dccdd44d
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ERBB4 LRP1B PKHD1 DNAH9 TMC2 POLE FAT3 PKHD1L1 GUCY2F SLC28A1 ABCB11 UNC80	4.98e-09	162	342	12	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2--L2-4\|Neuronal / cells hierarchy compared to all cells using T-Statistic	DLGAP1 ERBB4 FRMD4B ADCYAP1R1 PHKA1 ACAN SDK1 ROR1 ADAMTS5 RUNX2 SLC6A1 CNTNAP2 SLC4A4	5.57e-09	200	342	13	c65e6336725856c4b5f6aeba1cf86a23ec815d34
ToppCell	Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	DLGAP1 ERBB4 FRMD4B ADCYAP1R1 PHKA1 ACAN SDK1 ROR1 ADAMTS5 RUNX2 SLC6A1 CNTNAP2 SLC4A4	5.57e-09	200	342	13	117a25b3b9cdbc2e198381350a8362bee25e82e7
ToppCell	Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2\|Neuronal / cells hierarchy compared to all cells using T-Statistic	DLGAP1 ERBB4 FRMD4B ADCYAP1R1 PHKA1 ACAN SDK1 ROR1 ADAMTS5 RUNX2 SLC6A1 CNTNAP2 SLC4A4	5.57e-09	200	342	13	d459e51507bf26865e6e7e04411379ec82a3edf8
ToppCell	COVID-19-kidney-PEC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DLGAP1 CYP3A5 DSCAML1 MET FAT1 PKHD1 UGT2B7 MICAL3 SDK1 PRUNE2 LRP2 CDH6	7.51e-09	168	342	12	a086c306be430adf0632ba53e98cd8014d2de330
ToppCell	COVID-19-kidney-PCT-S2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DLGAP1 PDE4D DSCAML1 MET FAT1 PKHD1 UGT2B7 PRUNE2 SLC28A1 LRP2 SLC4A4 CDH6	1.63e-08	180	342	12	358923e4228035a3e90e2957392089219e90dcd7
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERBB4 LRP1B PKHD1 ADGRF1 TMC2 POLE CCDC7 GUCY2F SLC28A1 ABCB11 UNC80	1.71e-08	145	342	11	96712c68ab759d7ade0d912581a1a7c25dc6def8
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN ERBB4 RYR3 SLC24A4 GMPR SDK1 CHD7 RGS12 SLC6A1 NR2E1 ABCB11 PROX1	1.73e-08	181	342	12	062f00736eed96e4f4327615d093558dd7d82b20
ToppCell	COVID-19-Epithelial_cells-Airway_club\|COVID-19 / group, cell type (main and fine annotations)	ERBB4 PDE4D NEXMIF MET PTPN13 SFTPA2 PIGR SFTPA1 SDK1 SLC34A2 ARFGEF3 SLC4A4	2.21e-08	185	342	12	cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DLGAP1 FAT1 PKHD1 UGT2B7 MICAL3 SDK1 PRUNE2 SLC28A1 LRP2 WDFY3 CDH6 SAMD4A	2.49e-08	187	342	12	9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	ERBB4 PDE4D RYR3 SORT1 TSC22D1 COL14A1 SDK1 PRUNE2 TNC FAT3 MACF1 GPR176	2.64e-08	188	342	12	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN EML5 SLC24A2 NAV1 BACE2 PRUNE2 MIA3 ARFGEF3 CNTNAP2 ATP2A2 ATP2A3 UNC80	2.64e-08	188	342	12	a91443aa8fa8fa87f7501c59219daa0305bd0bbf
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ERBB4 FSTL5 FAT1 COL14A1 ATP11C SDK1 ROR1 ADAMTS5 TEX15 SLC6A1 PLA2R1 SPHKAP	2.64e-08	188	342	12	3139540a656c0436b2123ea50741ff8d00112165
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DLGAP1 PDE4D CYP3A5 MET FAT1 PKHD1 UGT2B7 SDK1 PRUNE2 SLC28A1 LRP2 CDH6	2.80e-08	189	342	12	28b502611829e4a24caff2562545c7db97686099
ToppCell	368C-Epithelial_cells-Epithelial-E_(AT2)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	ABCA3 MET SFTPA2 PIGR SFTPA1 ADGRF1 SDC4 DSG2 SLC34A2 ARFGEF3 LRP2 SLC4A4	2.80e-08	189	342	12	926b5fa3064b501a57ba78583e8af33532add455
ToppCell	368C-Epithelial_cells-Epithelial-E_(AT2)\|368C / Donor, Lineage, Cell class and subclass (all cells)	ABCA3 MET SFTPA2 PIGR SFTPA1 ADGRF1 SDC4 DSG2 SLC34A2 ARFGEF3 LRP2 SLC4A4	2.80e-08	189	342	12	6f2322d017b74a1757c81d6e06f50ead8c3dd0cc
ToppCell	LA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	PDE4D RYR3 SORT1 TSC22D1 COL14A1 SDK1 PRUNE2 TNC FAT3 MACF1 CDH6 GPR176	2.80e-08	189	342	12	6b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCell	AT2_cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	DLGAP1 ABCA3 ESRP2 PTPN13 SFTPA2 PIGR SFTPA1 ADGRF1 TNC SLC34A2 C1QTNF9 LRP2	2.80e-08	189	342	12	2d32f09efa982ae458568f6b1cd06bb5078d42a3
ToppCell	368C-Epithelial_cells\|368C / Donor, Lineage, Cell class and subclass (all cells)	ABCA3 MET SFTPA2 PIGR SFTPA1 ADGRF1 SDC4 DSG2 SLC34A2 ARFGEF3 LRP2 SLC4A4	2.97e-08	190	342	12	459811e88d3001816c2d89034e0921c24918c17f
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ERBB4 ABCA3 PDE4D MET PTPN13 SFTPA2 SFTPA1 NPC1 SLC34A2 ARFGEF3 FHDC1 SLC4A4	3.15e-08	191	342	12	a0332a4ef629510fb313ec119195c44a3f704a80
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DLGAP1 PDE4D MET FAT1 PKHD1 UGT2B7 MICAL3 SDK1 PRUNE2 LRP2 CDH6 SAMD4A	3.15e-08	191	342	12	1cb02007adb344f17ef73d58890f91298c7cf5a1
ToppCell	Epithelial-alveolar_epithelial_cell_type_2\|World / Lineage, Cell type, age group and donor	ERBB4 ABCA3 PDE4D MET PTPN13 SFTPA2 SFTPA1 SLC34A2 ARFGEF3 LRP2 FHDC1 SLC4A4	3.34e-08	192	342	12	58c3737be7acce39fd2b91d70d6d7b2bbaa4f710
ToppCell	facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AP1B1 SLC24A2 BACE2 PRUNE2 MIA3 ARFGEF3 SPHKAP CNTNAP2 FHDC1 ATP2A2 ATP2A3 UNC80	3.96e-08	195	342	12	bd8e24dd598990204998d1dd853ba7a53dc0107e
ToppCell	356C-Epithelial_cells-Epithelial-B_(AT2)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	ABCA3 PTPN13 SFTPA2 PIGR SFTPA1 ADGRF1 SDC4 DSG2 SLC34A2 ARFGEF3 NHSL1 FHDC1	4.43e-08	197	342	12	06ed8f293d4ee89f14dc2f43d6cae93bbc02508a
ToppCell	AT2_cells-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	DLGAP1 ABCA3 PDE4D PTPN13 SFTPA2 PIGR SFTPA1 TNC SLC34A2 ARFGEF3 LRP2 SLC4A4	4.43e-08	197	342	12	fd7bdfa6bf5966ebc11fdd13915769429540ddbf
ToppCell	356C-Epithelial_cells-Epithelial-B_(AT2)\|356C / Donor, Lineage, Cell class and subclass (all cells)	ABCA3 PTPN13 SFTPA2 PIGR SFTPA1 ADGRF1 SDC4 DSG2 SLC34A2 ARFGEF3 NHSL1 FHDC1	4.43e-08	197	342	12	c115d0a45545ed24259ad88872231bf4d4d389d2
ToppCell	ASK428-Epithelial-Type_2\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	ABCA3 PDE4D MET TSC22D1 PTPN13 SFTPA2 PIGR SFTPA1 SDC4 SLC34A2 ARFGEF3 FHDC1	4.69e-08	198	342	12	ec0d1801363adb70c6a26655b79d12b438c7417d
ToppCell	AT2_cells\|World / lung cells shred on cell class, cell subclass, sample id	ABCA3 PDE4D MET TSC22D1 PTPN13 SFTPA2 PIGR SFTPA1 SDC4 SLC34A2 ARFGEF3 FHDC1	4.69e-08	198	342	12	92c569c3b8a9fca2d4682cbf77ee8149bcc0a80a
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ERBB4 ABCA3 SPIRE1 FRMD4B MET PTPN13 SLC34A2 PPP4R4 ARFGEF3 LRP2 FHDC1 SLC4A4	4.69e-08	198	342	12	f948391296c261c473d339069a6d0f20ccd6f38f
ToppCell	Biopsy_Other_PF-Epithelial-AT2\|Biopsy_Other_PF / Sample group, Lineage and Cell type	ABCA3 MET PTPN13 SFTPA2 PIGR SFTPA1 SDC4 SLC34A2 ARFGEF3 LRP2 FHDC1 SLC4A4	4.95e-08	199	342	12	9a65acfe9bf500db72142469cf17bf0973540001
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ERBB4 ABCA3 PDE4D MET PTPN13 SFTPA2 SDC4 NPC1 SLC34A2 ARFGEF3 LRP2 FHDC1	4.95e-08	199	342	12	2dc33804f6691d7c9682e6c9b885e945fb97fc36
ToppCell	Epithelial_cells\|World / lung cells shred on cell class, cell subclass, sample id	ABCA3 PDE4D MET TSC22D1 PTPN13 SFTPA2 PIGR SFTPA1 SDC4 SLC34A2 ARFGEF3 FHDC1	4.95e-08	199	342	12	bbe69e44b7970f57628365ae771790f2b13d0cae
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	RELN ERBB4 FSTL5 ADCYAP1R1 FAT1 HEG1 ATP11C RGS12 SLC6A1 NR2E1 CNTNAP2 PROX1	5.23e-08	200	342	12	d0167f96314be78b6d867bbcc6e4396071d931b8
ToppCell	Neuronal-Inhibitory-iA\|Neuronal / cells hierarchy compared to all cells using T-Statistic	RELN ERBB4 FSTL5 ADCYAP1R1 FAT1 HEG1 ATP11C SDK1 RGS12 SLC6A1 NR2E1 PROX1	5.23e-08	200	342	12	5ef4a3dc18a44292184a59ced916183c0699b01e
ToppCell	Neuronal-Inhibitory-iB-iB_2(PVALB)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	DLGAP1 ERBB4 FRMD4B ADCYAP1R1 MEPE PHKA1 SDK1 ROR1 RUNX2 SLC6A1 CNTNAP2 SLC4A4	5.23e-08	200	342	12	1276bfa911fddada4235e12e3081baa53164574b
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FSTL5 CMYA5 MET FAT1 COL6A3 TNC GPR143 ADAMTS5 RUNX2 KANK2 SPHKAP SLC4A4	5.23e-08	200	342	12	09537dc25f8b8b4654a7c183827ee1522a41a4e0
ToppCell	343B-Epithelial_cells-Epithelial-A_(AT2)\|343B / Donor, Lineage, Cell class and subclass (all cells)	ABCA3 FAT2 PTPN13 SFTPA2 PIGR SFTPA1 SDC4 SLC34A2 ARFGEF3 LRP2 FHDC1	6.09e-08	164	342	11	d005cfd821b87548b075120bffe65a0be9860463
ToppCell	343B-Epithelial_cells-Epithelial-A_(AT2)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	ABCA3 FAT2 PTPN13 SFTPA2 PIGR SFTPA1 SDC4 SLC34A2 ARFGEF3 LRP2 FHDC1	6.09e-08	164	342	11	beaa13a75c3bb72446c85084d75e9fe3f15fd3d4
ToppCell	COVID-19-Heart-T_cell\|COVID-19 / Disease (COVID-19 only), tissue and cell type	RELN EXD1 SPTA1 FSTL5 ITGA4 RYR1 RYR3 SLC24A2 CNTNAP2 CSMD1 CDH4	9.33e-08	171	342	11	b2e753e811a7639956994609f73efcdb62d04f82
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ERBB4 NEXMIF MET FAT1 PTPN13 PIGR GYG2 GLRA3 XDH NBEA ARFGEF3	1.57e-07	180	342	11	b509c7d6bdfba672065fb722874bdc68de72ba1c
ToppCell	COVID-19-kidney-Distal_Epi_Doublet_(PCT)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ERBB4 LRP1B DSCAML1 MET PKHD1 UGT2B7 PRUNE2 SLC28A1 LRP2 SLC4A4 CDH6	1.75e-07	182	342	11	9d67717a6e13bcb54c1297a3e4e3abf4e51628a3
ToppCell	COPD-Epithelial-ATII\|World / Disease state, Lineage and Cell class	ERBB4 ABCA3 MET PTPN13 SFTPA2 PIGR SFTPA1 SLC34A2 ARFGEF3 LRP2 FHDC1	1.85e-07	183	342	11	8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ERBB4 ADCYAP1R1 RYR3 SLC24A4 GMPR SDK1 CHD7 RGS12 SLC6A1 NR2E1 PROX1	2.07e-07	185	342	11	0b5a0df58ae2ad8261f40f152775747af4f3937a
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ERBB4 FSTL5 FAT1 HEG1 COL14A1 ATP11C SDK1 ROR1 TEX15 SLC6A1 SPHKAP	2.18e-07	186	342	11	77592a6397b44b2b59a4fc39d7224dd95343efe6
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DLGAP1 PDE4D PKHD1 UGT2B7 TLN2 MICAL3 SDK1 PRUNE2 ASRGL1 LRP2 CDH6	2.18e-07	186	342	11	b87acc80b7baa41681e4ed11d5537b9fbf5832f5
ToppCell	COVID-19-kidney-tDL\|kidney / Disease (COVID-19 only), tissue and cell type	DLGAP1 CYP3A5 FAT1 UGT2B7 SDK1 PRUNE2 ROR1 SLC28A1 LRP2 SLC4A4 CDH6	2.31e-07	187	342	11	d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf
ToppCell	PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ABCA3 NEXMIF MET SFTPA1 SDC4 NPC1 SLC34A2 TEX15 CLIP4 ARFGEF3 LRP2	2.43e-07	188	342	11	562f5984efdbbcb8f53ddcee033ccbf9eb678425
ToppCell	COPD-Epithelial-ATII\|COPD / Disease state, Lineage and Cell class	ERBB4 ABCA3 MET PTPN13 SFTPA2 PIGR SFTPA1 TNC SLC34A2 ARFGEF3 FHDC1	2.43e-07	188	342	11	eb6d79d733b53f64ca615bb777c64ed456866549
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DLGAP1 MET FAT1 PKHD1 UGT2B7 MICAL3 SDK1 PRUNE2 LRP2 CDH6 SAMD4A	2.57e-07	189	342	11	3b48b0d220cc24d5170713d61fa91f5bb6c21841
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN ERBB4 CYP3A5 FSTL5 FAT1 HEG1 ATP11C SLC6A1 SPHKAP NR2E1 PROX1	2.70e-07	190	342	11	3b8d1e66ae68c1eee64095e75195d76d97e24026
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DLGAP1 PDE4D CYP3A5 PKHD1 MICAL3 SDK1 PRUNE2 SLC28A1 LRP2 CDH6 SAMD4A	2.70e-07	190	342	11	989d4eefd22d66ecb857836f8fdbcf41e3047f84
ToppCell	COVID-19-lung-AT2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ERBB4 ABCA3 PDE4D MET PTPN13 SFTPA2 SFTPA1 ADGRF1 SLC34A2 ARFGEF3 FHDC1	2.70e-07	190	342	11	27a1a86620fe9b5ee930d388b32352206485e6d0
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ERBB4 FRMD4B ADCYAP1R1 MEPE PHKA1 ACAN SDK1 ROR1 RUNX2 SLC6A1 SLC4A4	2.70e-07	190	342	11	3f22c118d552345f731d4d49f0bcb5765d93de3b
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	ERBB4 PDE4D CMYA5 JAK2 FAT1 ALPK3 MICAL3 FLNC ROR1 ATP2A2 SAMD4A	2.70e-07	190	342	11	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ERBB4 FRMD4B ADCYAP1R1 PHKA1 ACAN SDK1 ADAMTS5 RUNX2 CLIP4 SLC6A1 SLC4A4	2.70e-07	190	342	11	39ab890104b4264c68a968f920f4ccd84f0bc681
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN ERBB4 CYP3A5 FSTL5 FAT1 HEG1 ATP11C SLC6A1 SPHKAP NR2E1 PROX1	2.70e-07	190	342	11	dc655e4782aab274f0c9b6e36a5ce315e3a1a4b9
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DLGAP1 PKHD1 UGT2B7 TLN2 MICAL3 SDK1 PRUNE2 SLC28A1 LRP2 SLC4A4 CDH6	2.85e-07	191	342	11	1c1d13144259b998d4a0e85142f7afef2ef1e63f
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN SLC24A2 GMPR BACE2 PRUNE2 MIA3 ARFGEF3 CNTNAP2 ATP2A2 ATP2A3 UNC80	2.85e-07	191	342	11	3387b95a3f2445c672d407922fdce3a91eabaef8
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE4D CMYA5 LRP1B SORT1 PTPN13 NBEAL2 PKHD1 ADGRF1 SDK1 LRBA TJP3	2.85e-07	191	342	11	3e828cffa24ded19f591a7ed6c1fe88ad57fdcac
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DLGAP1 PKHD1 UGT2B7 TLN2 MICAL3 SDK1 PRUNE2 SLC28A1 LRP2 SLC4A4 CDH6	2.85e-07	191	342	11	3c464645d0e7e423f791bd63bf5bcf11f6b590d3
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN TSC22D1 GMPR BACE2 PRUNE2 MIA3 ARFGEF3 PEBP1 ATP2A2 ATP2A3 UNC80	2.85e-07	191	342	11	a251b134f67a0a1ef3a42f50042f128a17f20b22
ToppCell	wk_20-22-Epithelial-Distal_epithelial_progenitor-epi-tip_late\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	ABCA3 ESRP2 PTPN13 SFTPA2 PKHD1 UGT2B7 SDC4 SLC34A2 NHSL1 SLC4A4 CDH3	3.00e-07	192	342	11	87b60014202633a4f6d19b09a5dd9276c2edecfb
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN ERBB4 FSTL5 ADCYAP1R1 HEG1 SDK1 RUNX2 RGS12 SLC6A1 CNTNAP2 PROX1	3.00e-07	192	342	11	bf1943715085c4124b1675888b0615c9500ec888
ToppCell	wk_20-22-Epithelial-Distal_epithelial_progenitor\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	ABCA3 ESRP2 PTPN13 SFTPA2 PKHD1 UGT2B7 SDC4 SLC34A2 NHSL1 SLC4A4 CDH3	3.00e-07	192	342	11	fa2420d6117d4800f60ef6a24bcf8bf54593cd1f
ToppCell	COPD-Myeloid-DC_Mature\|Myeloid / Disease state, Lineage and Cell class	TNFRSF11A ITGA4 DSCAML1 NAV1 ATP11C SDK1 DSG2 ROR1 LRRK1 PACS1 FSCN1	3.00e-07	192	342	11	baebd462f464e7d0e462d07a74bb5d685a9fc3b6
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ACTB MEPE FAT1 MICAL3 COL6A3 ROR1 RUNX2 ISG15 PEBP1 SPHKAP SLC4A4	3.16e-07	193	342	11	e2b455387d1de7812305200a2041a0f4759a6f54
ToppCell	droplet-Heart-HEART-1m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEXMIF BACE2 FOXC1 FLNC VWF COMP PCDHB3 NR1D1 PKHD1L1 HMCN1 CDH4	3.16e-07	193	342	11	d0a5f212f8e8a13dbbe3e41df92548ef82eef70b
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	MAN2A1 ZXDA CPLANE1 CEP97 MED13 RANBP2 FRYL MED1 ARFGEF3 APPL1 WDFY3	3.16e-07	193	342	11	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	normal_Lung-Epithelial_cells-AT2\|normal_Lung / Location, Cell class and cell subclass	ABCA3 MET TSC22D1 PTPN13 SFTPA2 PIGR SFTPA1 SDC4 SLC34A2 ARFGEF3 FHDC1	3.16e-07	193	342	11	80ad1bdc50ecb8a50362f718248441cae20904a6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ERBB4 PDE4D CMYA5 FAT1 PTPN13 PKHD1 UGT2B7 PRUNE2 LRP2 LRBA SLC4A4	3.16e-07	193	342	11	3866667dd221612589ae50f5c52f73a183a49ce6
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ERBB4 ABCA3 PDE4D SPIRE1 FRMD4B MET PTPN13 NPC1 ARFGEF3 FHDC1 SLC4A4	3.33e-07	194	342	11	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE4D NEXMIF CMYA5 ITPK1 FAT1 ADGRF1 SDK1 CYSLTR2 ROR1 NBEA TJP3	3.33e-07	194	342	11	4579b4a44f7c731553a284843c296866027d7c0e
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CMYA5 CSMD2 PKDREJ LRP1B ACAN GLRB NAV1 HFM1 CEP97 SLC6A1	3.50e-07	155	342	10	77fdae85d36efb776db977eb424b32487ef222e4
ToppCell	AT2_cells-Donor_06\|World / lung cells shred on cell class, cell subclass, sample id	ABCA3 PDE4D PAK6 PTPN13 SFTPA2 PIGR SFTPA1 SDC4 ASRGL1 SLC34A2 FHDC1	3.51e-07	195	342	11	b0cea3f4e59635913d243612f2e8cf4c7b34e726
ToppCell	(7)_Epithelial-A_(AT2)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	ABCA3 MET PTPN13 SFTPA2 PIGR SFTPA1 SDC4 SLC34A2 ARFGEF3 NHSL1 FHDC1	3.51e-07	195	342	11	c9a6c65ee18d83bf34a4713d306a6e30db1325c2
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN ERBB4 CYP3A5 FSTL5 FAT1 HEG1 ATP11C RUNX2 SLC6A1 SPHKAP PROX1	3.51e-07	195	342	11	98ca9f3aa36211dde1e6f7f3817b9418c95e583e
Drug	THAZ	ACAA1 GLRA1 GLRB GLRA3	6.51e-07	6	332	4	CID000171289
Drug	thio-THIP	ACAA1 GLRA1 GLRB GLRA3	6.51e-07	6	332	4	CID000656720
Drug	mV GABA	GLRA1 GLRB MED12 GLRA3	6.51e-07	6	332	4	CID000128435
Drug	j I N	MAN2A1 TRRAP MET ACAN UGT2B4 UGT2B10 SYNM TNC ADAMTS5 SLC6A1 FXR1	1.18e-06	117	332	11	CID005311104
Drug	Chlorpropamide [94-20-2]; Up 200; 14.4uM; MCF7; HT_HG-U133A	PKDREJ ITPK1 PIGR SUPT6H GMPR CPLANE1 PRUNE2 MIA3 CDC42BPA WNT2B SLC34A2 PPP4R4 CNTNAP2 SAMD4A	1.21e-06	196	332	14	3210_UP
Drug	alpha-estradiol; Up 200; 0.01uM; HL60; HT_HG-U133A	PDE4D SORT1 HEG1 MAN1A2 PIGR TLN2 FOXC1 CDC42BPA XDH OR1D2 SLC28A1 SLC4A4 PBXIP1 CDH15	1.21e-06	196	332	14	6169_UP
Drug	Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; PC3; HT_HG-U133A	MKRN3 CD52 ITPK1 ACAN ACAA2 PGGHG ZNF407 LRRK1 PPP4R4 LRP2 PROX1 SYMPK TJP3 EPHB1	1.54e-06	200	332	14	3714_UP
Drug	pregnenolone-16 alpha-carbonitrile	CYP3A5 UGT2B4 SYNM CYP3A43 SLC28A2 ABCB11 FSCN1 PCNT	5.80e-06	67	332	8	CID000015032
Drug	Anabasine [494-52-0]; Up 200; 24.6uM; MCF7; HT_HG-U133A	ERBB4 PKDREJ RYR1 ACAN GYG2 ACAA2 CDON TNC WNT2B GLRA3 CNTNAP2 FYB1 CDH6	6.22e-06	195	332	13	6074_UP
Drug	Benzbromarone [3562-84-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A	JAK2 HEG1 PLCG1 CDON ANKFY1 NRF1 VPS50 RGS12 ZNF335 CNTNAP2 WDFY3 SLC4A4 ATP2A3	6.58e-06	196	332	13	5015_DN
Drug	Amidopyrine [58-15-1]; Down 200; 17.2uM; MCF7; HT_HG-U133A	ESRP2 HEG1 EXOC7 PICK1 CDON NPR2 ANKFY1 TLN1 MACF1 FSCN1 ATP2A3 PBXIP1 SYMPK	6.95e-06	197	332	13	2222_DN
Drug	Lorglumide sodium salt [97964-56-2]; Up 200; 8.4uM; PC3; HT_HG-U133A	ERBB4 MET NOD1 HDAC6 COMP TEX15 NR1D1 RGS12 MYO1F LRP2 CDH6 PROX1 TJP3	6.95e-06	197	332	13	4658_UP
Drug	(S)-(-)-Atenolol [93379-54-5]; Up 200; 15uM; PC3; HT_HG-U133A	GON4L NOD1 CPSF1 ACAA2 SLC34A2 NR1D1 CD160 CCDC7 PEAK1 SLC4A4 CDH6 SAMD4A TJP3	6.95e-06	197	332	13	6725_UP
Drug	Methocarbamol [532-03-6]; Down 200; 16.6uM; MCF7; HT_HG-U133A	CD52 ZNF224 JAK2 CDC42BPA NRF1 PGGHG VPS50 GPR143 CLIP4 TLN1 WDFY3 SLC4A4 CDH6	7.34e-06	198	332	13	2274_DN
Drug	lavendustin A	ERBB4 RYR1 RYR3 JAK2 MET GLRA1 GLRB CNGA3 GLRA3 LRBA MAP2K1 MAP2K2	8.41e-06	171	332	12	CID000003894
Drug	procarbazine	CYP3A5 ALDH18A1 PLXNA1 ASRGL1 COMP SYNM XDH PALB2 GPR176	8.78e-06	93	332	9	CID000004915
Drug	protostrychnine	GLRA1 GLRB GLRA3	1.22e-05	4	332	3	CID005320746
Drug	7-nitroindoline	GLRA1 GLRB GLRA3	1.22e-05	4	332	3	CID013566747
Drug	SC-49648	GLRA1 GLRB GLRA3	1.22e-05	4	332	3	CID000195696
Drug	akuammiline	GLRA1 GLRB GLRA3	1.22e-05	4	332	3	CID005367018
Drug	N-methyl-THIP	GLRA1 GLRB GLRA3	1.22e-05	4	332	3	CID000134373
Drug	SC-48981	GLRA1 GLRB GLRA3	1.22e-05	4	332	3	CID000126573
Drug	iso-THAZ	GLRA1 GLRB GLRA3	1.22e-05	4	332	3	CID003047783
Drug	2-(phosphonomethyl)phenylalanine	GLRA1 GLRB GLRA3	1.22e-05	4	332	3	CID000383689
Drug	NSC381080	GLRA1 GLRB GLRA3	1.22e-05	4	332	3	CID000165497
Drug	SC-50132	GLRA1 GLRB GLRA3	1.22e-05	4	332	3	CID000195719
Drug	SR 42641	GLRA1 GLRB GLRA3	1.22e-05	4	332	3	CID000129049
Drug	PCB 66	CYP3A5 RYR1 RYR3 PCBP1	1.35e-05	11	332	4	CID000036185
Drug	2a-c	ACTG1 NPC1 XDH NLRP14 MAP2K1 MAP2K2	1.46e-05	37	332	6	CID000007264
Drug	colchicoside	ACAA1 GLRA1 GLRB GLRA3	2.00e-05	12	332	4	CID000092763
Drug	Loperamide hydrochloride [34552-83-5]; Up 200; 7.8uM; PC3; HT_HG-U133A	SETD1A ERBB4 SYT12 FBXO22 NOD1 EXOC7 WNT2B RGS12 PPP4R4 CCDC7 CDH15 SAMD4A	2.30e-05	189	332	12	4672_UP
Drug	orthovanadate	ERBB4 PDE4D ACP3 ACTB ACTG1 RYR1 JAK2 BRD8 PTPN13 ALPK3 PLCG1 DNAH9 TNC NLRP14 ABCB11 LRBA MAP2K1 ATP2A2 ATP2A3	2.42e-05	435	332	19	CID000061672
Drug	poly(3-hydroxybutyrate-co-3-hydroxyvalerate	ACAA1 ACAN ACAA2 RUNX2	2.86e-05	13	332	4	CID000107801
Drug	Heliotrine [303-33-3]; Up 200; 12.8uM; HL60; HT_HG-U133A	CYP3A5 SPART TNFRSF11A HEG1 GLRB GYG2 PLCG1 NPR2 SLC34A2 NR1D1 SLC4A4 PBXIP1	2.98e-05	194	332	12	2180_UP
Drug	Ergocryptine-alpha [511-09-1]; Up 200; 7uM; PC3; HT_HG-U133A	ABCA3 PDE4D HEG1 FBXO22 GLRA1 GYG2 TLN2 GMPR MAP3K19 CYP3A43 WNT2B TEX15	2.98e-05	194	332	12	4552_UP
Drug	Lindane	GLRA1 GLRB GLRA3	3.01e-05	5	332	3	DB00431
Drug	pleiocarpamine	GLRA1 GLRB GLRA3	3.01e-05	5	332	3	CID000558637
Drug	azetidine-3-carboxylic acid	GLRA1 GLRB GLRA3	3.01e-05	5	332	3	CID000093192
Drug	Cao C	GLRA1 GLRB GLRA3	3.01e-05	5	332	3	CID000166617
Drug	oxanilide	GLRA1 GLRB GLRA3	3.01e-05	5	332	3	CID000069288
Drug	iso-THAO	GLRA1 GLRB GLRA3	3.01e-05	5	332	3	CID000127199
Drug	ALX1393	GLRA1 GLRB GLRA3	3.01e-05	5	332	3	CID016078939
Drug	mafoprazine	GLRA1 GLRB GLRA3	3.01e-05	5	332	3	CID000071241
Drug	gevotroline	GLRA1 GLRB GLRA3	3.01e-05	5	332	3	CID000060546
Drug	Bicuculline (+) [485-49-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A	TNFRSF11A RYR1 MAN1A2 TLN2 GMPR PGGHG WNT2B GRB10 CLIP4 PACS1 WDFY3 SLC4A4	3.13e-05	195	332	12	2796_UP
Drug	Cephalothin sodium salt [58-71-9]; Up 200; 9.6uM; HL60; HT_HG-U133A	ITPK1 MET GLE1 COL14A1 PLCG1 SLC34A2 TEX15 RUNX2 ATXN3L CNTNAP2 TJP3 EPHB1	3.13e-05	195	332	12	2517_UP
Drug	Ranitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A	SORT1 JAK2 MET NOD1 TLN2 GMPR EXOC7 CEP97 MED1 CNTNAP2 MACF1 WDFY3	3.29e-05	196	332	12	5425_DN
Drug	Aceclofenac [89796-99-6]; Up 200; 11.2uM; PC3; HT_HG-U133A	ZNF224 COL14A1 PLXNA1 PICK1 CDON NPR2 RUNX2 BBS7 MYO1F SLC4A4 SLC26A6 SYMPK	3.29e-05	196	332	12	7269_UP
Drug	Aztreonam [78110-38-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A	PDE4D CYP3A5 ZNF230 MET MAN1A2 EXOC7 FLNC ZNF407 ADAMTS5 CDH6 MUC6 CDH17	3.29e-05	196	332	12	2282_UP
Drug	Delcorine; Down 200; 8.4uM; MCF7; HT_HG-U133A	ITPK1 JAK2 HSPA12A TLN2 MICAL3 EXOC7 OR1D2 CNTNAP2 WDFY3 SLC4A4 ATP2A3 SYMPK	3.29e-05	196	332	12	3613_DN
Drug	Indoprofen [31842-01-0]; Up 200; 14.2uM; PC3; HT_HG-U133A	CYP3A5 ACP3 ZKSCAN8 ITPK1 HEG1 NPR2 PGGHG CCDC7 OR1D2 SLC28A1 SAMD4A EPHB1	3.46e-05	197	332	12	4249_UP
Drug	Homosalate [118-56-9]; Down 200; 15.2uM; PC3; HT_HG-U133A	ABCA3 ZNF224 JAK2 MET BRCA2 TLN2 PICK1 TNC NR1D1 SLC4A4 CDH6 PBXIP1	3.46e-05	197	332	12	3797_DN
Drug	Triflupromazine hydrochloride [1098-60-8]; Up 200; 10.2uM; MCF7; HT_HG-U133A	SPART ITPK1 NOD1 MAGED2 GMPR VEZT VPS50 GRB10 PACS1 TAF5L ATP2A3 CDH6	3.46e-05	197	332	12	1691_UP
Drug	Thiorphan [76721-89-6]; Up 200; 15.8uM; MCF7; HT_HG-U133A	ACP3 ZNF230 MAN1A2 PIGR DNAH9 CDC42BPA TNC NR1D1 RGS12 CLIP4 PACS1 CDH17	3.46e-05	197	332	12	2752_UP
Drug	Natamycin [7681-93-8]; Up 200; 6uM; PC3; HT_HG-U133A	NBEAL2 PLCG1 CDON PPP4R4 CLIP4 MYO1F SLC4A4 QTRT1 GPR176 PBXIP1 SAMD4A SYMPK	3.46e-05	197	332	12	5809_UP
Drug	Lymecycline [992-21-2]; Up 200; 6.6uM; PC3; HT_HG-U133A	ABCA3 ITPK1 CPLANE1 HDAC6 SLC34A2 LRRK1 NR1D1 OR1D2 CLIP4 GPR176 PBXIP1 SAMD4A	3.64e-05	198	332	12	7291_UP
Drug	Calciferol [50-14-6]; Up 200; 10uM; MCF7; HT_HG-U133A	EDC4 SUPT6H ANKFY1 NRF1 SYNM GRB10 FRYL MED1 AP3B1 ISG15 WDFY3 QTRT1	3.64e-05	198	332	12	5346_UP
Drug	Pralidoxime chloride [51-15-0]; Up 200; 23.2uM; MCF7; HT_HG-U133A	SPTA1 ITGA4 MET CYP3A43 RGS12 PPP4R4 OR1D2 LRP2 PEAK1 SLC4A4 CDH6 GPR176	3.64e-05	198	332	12	6443_UP
Drug	Procarbazine hydrochloride [366-70-1]; Down 200; 15.6uM; MCF7; HT_HG-U133A	SPART GON4L GYG2 TLN2 GMPR MICAL3 NPR2 GPR143 MED1 MYO1F WDFY3 TJP3	3.64e-05	198	332	12	5452_DN
Drug	LY 294002; Up 200; 0.1uM; HL60; HT_HG-U133A	SYT12 CYP3A5 RYR1 ITPK1 MET CDON NPR2 VWF RGS12 OR1D2 SLC4A4 ATP2A3	3.64e-05	198	332	12	6175_UP
Drug	Phenelzine sulfate [156-51-4]; Up 200; 17uM; MCF7; HT_HG-U133A	CYP3A5 ZNF224 GYG2 GMPR KLHL18 CYSLTR2 SLC34A2 RUNX2 OR1D2 TLN1 SAMD4A EPHB1	3.64e-05	198	332	12	2319_UP
Drug	Sulfamethoxypyridazine [80-35-3]; Up 200; 14.2uM; HL60; HT_HG-U133A	CD52 SPTA1 COL14A1 TLN2 KLHL18 COL6A3 SYNM SLC34A2 CD160 LRP2 FYB1 MUC6	3.64e-05	198	332	12	2550_UP
Drug	Amodiaquin dihydrochloride dihydrate [6398-98-7]; Up 200; 8.6uM; MCF7; HT_HG-U133A	MKRN3 CD52 SPTA1 ADCYAP1R1 SORT1 JAK2 HEG1 FLNC PGGHG GLRA3 WDFY3 ATP2A3	3.82e-05	199	332	12	3186_UP
Drug	C070379	RYR1 RYR3 JAK2 RANBP2 VWF RUNX2 LRBA SLC4A4 MAP2K1 MAP2K2 ATP2A2 ATP2A3	3.82e-05	199	332	12	CID003034747
Drug	Captopril [62571-86-2]; Up 200; 17.2uM; MCF7; HT_HG-U133A	PDE4D GYG2 TLN2 EXOC7 PLXNA1 CDC42BPA PGGHG XDH RUNX2 CLIP4 SLC4A4 CDH6	3.82e-05	199	332	12	1488_UP
Drug	1,1-dimethylbiguanide hydrochloride; Up 200; 10uM; MCF7; HG-U133A	SYT12 GON4L ACAN ACAA2 PLCG1 PRUNE2 FLNC AMBRA1 CCDC7 CEP83 TAF5L SLC4A4	3.82e-05	199	332	12	1_UP
Drug	NP-EGTA	RYR1 RYR3 SYNM TNC	3.96e-05	14	332	4	CID000183793
Drug	diad	RYR1 RYR3 BACE2 NRF1 GRB10	4.77e-05	28	332	5	CID000075555
Drug	mPEG	MEPE AGA ASRGL1 PEBP1 APPL1 AKAP11	5.27e-05	46	332	6	CID000008019
Drug	2-hydroxyestriol	UGT2B4 UGT2B7 UGT2B10	5.95e-05	6	332	3	CID000014688
Drug	thiomuscimol	GLRA1 GLRB GLRA3	5.95e-05	6	332	3	CID000005448
Drug	AC1L90PQ	GLRA1 GLRB GLRA3	5.95e-05	6	332	3	CID000436036
Drug	caged glycine	GLRA1 GLRB GLRA3	5.95e-05	6	332	3	CID000192642
Drug	brometone	GLRA1 GLRB GLRA3	5.95e-05	6	332	3	CID000006424
Drug	minaxolone	GLRA1 GLRB GLRA3	5.95e-05	6	332	3	CID000071960
Drug	Blue Shield	SPTA1 GLRA1 GLRB GLRA3 FYB1	6.76e-05	30	332	5	CID000014830
Drug	Vanadates	ITGA4 ZNF623 MED24 PHKA1 MET TSC22D1 EML5 NAV1 GYG2 TLN2 ATP11C CPLANE1 CDON NPR2 ASRGL1 TNC ROR1 PCDHB12 SLC34A2 DEPDC1 CHD7 POMT1 RUNX2 MED1 AP3B1 AARSD1 PPP4R4 ATL1 ARFGEF3 PLA2R1 ABCB11 FHDC1 SLC4A4 FSCN1 MAP2K1 CDH4 CDH6	8.38e-05	1302	332	37	ctd:D014638
Drug	lomustine	CYP3A5 DDB2 PLXNA1 ASRGL1 COMP	9.32e-05	32	332	5	CID000003950
Drug	2,2,2-trichloroethanol	CYP2C18 CYP3A5 GLRA1 UGT2B4 UGT2B7 UGT2B10 CYP3A43	9.40e-05	73	332	7	CID000008259
Drug	L-serinamide	GLRA1 GLRB GLRA3	1.03e-04	7	332	3	CID000101138
Drug	Boc-glycine	GLRA1 GLRB GLRA3	1.03e-04	7	332	3	CID000078288
Drug	alpha-EMTBL	GLRA1 GLRB GLRA3	1.03e-04	7	332	3	CID000128423
Drug	CID189778	GLRA1 GLRB GLRA3	1.03e-04	7	332	3	CID000189778
Drug	propyl methanethiosulfonate	GLRA1 GLRB GLRA3	1.03e-04	7	332	3	CID000529387
Drug	thiocolchicoside	GLRA1 GLRB GLRA3	1.03e-04	7	332	3	CID000072067
Drug	PK 8165	GLRA1 GLRB GLRA3	1.03e-04	7	332	3	CID000071219
Drug	Benfotiamine [22457-89-2]; Down 200; 8.6uM; HL60; HT_HG-U133A	SETD1A CD52 CYP3A5 MAN1A2 MAGED2 PLCG1 EXOC7 AP3B1 OR1D2 FYB1 CDH6	1.32e-04	193	332	11	2177_DN
Drug	Methylhydantoin-5-(L) [40856-73-3]; Down 200; 35uM; MCF7; HT_HG-U133A	ZNF230 JAK2 GMPR CDC42BPA NRF1 VPS50 GPR143 XDH NR1D1 CLIP4 SAMD4A	1.32e-04	193	332	11	3378_DN
Drug	Y-27632; Up 200; 3uM; MCF7; HT_HG-U133A_EA	SETD1A ZNF224 HEG1 GYG2 EXOC7 CDC42BPA GRB10 AMBRA1 CLIP4 TLN1 SYMPK	1.32e-04	193	332	11	948_UP
Drug	Viomycin sulfate [37883-00-4]; Down 200; 5.2uM; MCF7; HT_HG-U133A	SPART MET NBEAL2 PLCG1 CDON SUPT20H CDC42BPA TIGD6 FSCN1 ATP2A3 SYMPK	1.38e-04	194	332	11	7036_DN
Drug	Halcinonide [3093-35-4]; Down 200; 8.8uM; HL60; HT_HG-U133A	SETD1A CD52 MAN1A2 PRR14L PLCG1 CEP97 ADAMTS5 OR1D2 GEMIN4 ATP2A2 CDH6	1.38e-04	194	332	11	2185_DN
Drug	Chlorpromazine hydrochloride [69-09-0]; Down 200; 11.2uM; PC3; HT_HG-U133A	TNFRSF11A EDC4 PTPN13 EXOC7 PRRC2A RANBP2 MED1 GEMIN4 APPL1 GEMIN6 QTRT1	1.38e-04	194	332	11	1822_DN
Drug	Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; PC3; HT_HG-U133A	PDE4D MET ACAN GLRB ACAA2 EXOC7 PICK1 CDC42BPA NR1D1 CNTNAP2 CDH6	1.38e-04	194	332	11	3779_DN
Drug	sobetirome	BRD8 MED12 NPR2 MED1 NR1D1 SLC6A1 GUCY2F	1.43e-04	78	332	7	CID009862248
Drug	AC1L380G	RYR1 RYR3 ATP2A2 ATP2A3	1.45e-04	19	332	4	CID000084698
Drug	Meptazinol hydrochloride [59263-76-2]; Up 200; 14.8uM; MCF7; HT_HG-U133A	CYP3A5 GON4L SORT1 MET HSPA12A MAN1A2 PICK1 SLC4A4 FSCN1 ATP2A2 SYMPK	1.45e-04	195	332	11	7326_UP
Drug	NSC3260	ACTB ACTG1 RYR1 RYR3 PRRC2A SUPT20H TNC LRBA ATP2A2 ATP2A3 CDH3	1.45e-04	195	332	11	CID000220461
Drug	estradiol, USP; Up 200; 0.1uM; MCF7; HT_HG-U133A	CD52 SYT12 ITPK1 JAK2 CDON GPR143 GRB10 XDH RGS12 ADGB CDH6	1.45e-04	195	332	11	5205_UP
Drug	Furaltadone hydrochloride [3759-92-0]; Up 200; 11uM; PC3; HT_HG-U133A	SPTA1 FBXO22 ACAN CPSF1 TLN2 ZNF407 ADAMTS5 CNTNAP2 SLC4A4 CDH6 SAMD4A	1.45e-04	195	332	11	4313_UP
Drug	Cyclacillin [3485-14-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	FRMD4B GYG2 PRR14L CDC42BPA PGGHG GPR143 OR1D2 BBS7 CNTNAP2 FSCN1 SLC26A6	1.45e-04	195	332	11	4358_DN
Disease	Schizophrenia	SETD1A DLGAP1 RELN ERBB4 PDE4D GPR50 CYP3A5 ACTB CMYA5 CSMD2 TRRAP ADCYAP1R1 MET HSPA12A EML5 AGA MICB NAV1 MED12 PICK1 GRB10 AMBRA1 RGS12 SLC6A1 TET1 NR2E1 CNTNAP2 LRP2 CSMD1 ATP2A2 PCNT	1.78e-08	883	326	31	C0036341
Disease	congenital heart disease (implicated_via_orthology)	USP17L7 USP17L1 USP17L3 USP17L4 USP17L10 CHD7 KMT2D LRP2 USP17L8	6.96e-08	69	326	9	DOID:1682 (implicated_via_orthology)
Disease	serum gamma-glutamyl transferase measurement	SYT12 ACTG1 GON4L MET SLC24A4 SLC24A2 NBEAL2 PKHD1 UGT2B4 UGT2B7 UGT2B10 MICAL3 PLCG1 PRRC2A MED13 CDC42BPA PNKD MAP4K5 TLN1 ABCB11 DDRGK1 YY1AP1 LRBA CSMD1 CDH6 MUC6 PROX1 TJP3 EPHB1	4.33e-07	914	326	29	EFO_0004532
Disease	plasma clozapine-to-N-desmethylclozapine ratio measurement	CYP2C18 UGT2B4 UGT2B7 UGT2B10	1.76e-06	9	326	4	EFO_0600040
Disease	melanoma	ERBB4 ERCC5 TRRAP LRP1B DDB2 MET BRCA2 UGT2B10 ZNF438 HDAC6 TNC MAP2K1 MAP2K2	4.42e-06	248	326	13	C0025202
Disease	Cutaneous Melanoma	ERBB4 ERCC5 TRRAP DDB2 MAP2K1 MAP2K2	5.64e-06	41	326	6	C0151779
Disease	autism spectrum disorder (implicated_via_orthology)	ABCA3 NEXMIF DSCAML1 MET NBEA CHD7 FXR1 CNTNAP2 WDFY3 LRBA	7.93e-06	152	326	10	DOID:0060041 (implicated_via_orthology)
Disease	primary ovarian insufficiency (implicated_via_orthology)	USP17L7 USP17L1 USP17L3 USP17L4 USP17L10 USP17L8	1.12e-05	46	326	6	DOID:5426 (implicated_via_orthology)
Disease	Hepatic fibrosis	ERBB4 SLC24A4 SLC24A2 SDK1 CDH3 CDH15	1.63e-05	49	326	6	HP_0001395
Disease	Bipolar Disorder	RELN ERBB4 GPR50 FSTL5 ACTB BDKRB2 BRCA2 PLCG1 ROR1 NR1D1 PALB2 PACS1 NR2E1 CNTNAP2 CSMD1 CDH17 PCNT	2.68e-05	477	326	17	C0005586
Disease	Malignant neoplasm of breast	ERBB4 ABCA3 APC2 PKDREJ BRCA2 MAGED2 ABRAXAS1 DNAH9 PRRC2A MED12 ZNF438 VWF ROR1 XDH PALB2 EPG5 KMT2D NLRP14 FXR1 CCT5 TRAPPC12 GUCY2F ASL SLC28A1 MACF1 APPL1 LRBA ATP2A3	2.71e-05	1074	326	28	C0006142
Disease	metabolonic lactone sulfate measurement	CYP2C18 CYP3A5 ZNF394 CYP3A43	4.97e-05	19	326	4	EFO_0800659
Disease	Malignant neoplasm of prostate	PDE4D CYP2C18 CYP3A5 PAK6 LRP1B JAK2 MET BRCA2 MED12 FOXC1 HDAC6 CYP3A43 CHD7 PALB2 KMT2D SF3B1 LRP2 TMF1 TJP3	6.46e-05	616	326	19	C0376358
Disease	Prostatic Neoplasms	PDE4D CYP2C18 CYP3A5 PAK6 LRP1B JAK2 MET BRCA2 MED12 FOXC1 HDAC6 CYP3A43 CHD7 PALB2 KMT2D SF3B1 LRP2 TMF1 TJP3	6.46e-05	616	326	19	C0033578
Disease	myositis	TRAF6 PDE4D HLA-DQB2 AP1B1 MICB	6.75e-05	39	326	5	EFO_0000783
Disease	gout	OR13C8 FRMD4B BDKRB2 MEPE FAT1 RUNX2 CD160 MAP4K5 CNTNAP2 LRP2	7.05e-05	196	326	10	EFO_0004274
Disease	Moyamoya disease (implicated_via_orthology)	ACTB ACTG1 POTEKP	7.18e-05	8	326	3	DOID:13099 (implicated_via_orthology)
Disease	autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology)	ACTB ACTG1 POTEKP	7.18e-05	8	326	3	DOID:0110550 (implicated_via_orthology)
Disease	Baraitser-Winter syndrome 1 (implicated_via_orthology)	ACTB ACTG1 POTEKP	7.18e-05	8	326	3	DOID:0081112 (implicated_via_orthology)
Disease	thoracic aortic aneurysm (implicated_via_orthology)	ACTB ACTG1 POTEKP	7.18e-05	8	326	3	DOID:14004 (implicated_via_orthology)
Disease	C-peptide measurement	HLA-DQB2 BACE2 MUC19 MAP4K5	9.14e-05	22	326	4	EFO_0005187
Disease	Tinnitus	ITPK1 PTPN13 SFTPA2 PKHD1 SFTPA1 SDK1 SPATA31A1 CNTNAP2	1.03e-04	130	326	8	HP_0000360
Disease	Global developmental delay	APC2 SPART TRRAP AP1B1 GLRA1 NBEA TRAPPC12 ZNF335	1.21e-04	133	326	8	C0557874
Disease	Cleidocranial Dysplasia	RYR1 RUNX2	1.22e-04	2	326	2	C0008928
Disease	Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation	ACTB ACTG1	1.22e-04	2	326	2	C1855722
Disease	ocular albinism 1 (implicated_via_orthology)	SLC24A5 GPR143	1.22e-04	2	326	2	DOID:0050633 (implicated_via_orthology)
Disease	Baraitser-Winter syndrome	ACTB ACTG1	1.22e-04	2	326	2	cv:C1853623
Disease	salivary gland cancer (implicated_via_orthology)	GON4L YY1AP1	1.22e-04	2	326	2	DOID:8850 (implicated_via_orthology)
Disease	Fryns-Aftimos Syndrome	ACTB ACTG1	1.22e-04	2	326	2	C1853623
Disease	esophagus squamous cell carcinoma (is_implicated_in)	ERBB4 FAT1 BRCA2 COL14A1 KMT2D	1.36e-04	45	326	5	DOID:3748 (is_implicated_in)
Disease	intestinal atresia (implicated_via_orthology)	ACTB ACTG1 POTEKP	1.51e-04	10	326	3	DOID:10486 (implicated_via_orthology)
Disease	patent ductus arteriosus (implicated_via_orthology)	ACTB ACTG1 POTEKP	1.51e-04	10	326	3	DOID:13832 (implicated_via_orthology)
Disease	Intellectual Disability	SETD1A APC2 GON4L TRRAP AP1B1 MED13 TLK2 PTPN23 NBEA ATL1 PACS1 BBS7 ZNF335 LRP2 MACF1	1.53e-04	447	326	15	C3714756
Disease	lung non-small cell carcinoma (is_implicated_in)	ERCC5 LRP1B JAK2 FAT1 PLCG1 POLE RUNX2 KMT2D	1.64e-04	139	326	8	DOID:3908 (is_implicated_in)
Disease	Agouti-related protein measurement	ESRP2 CDH3 CDH15 CDH17	2.10e-04	27	326	4	EFO_0008016
Disease	monoclonal gammopathy	ERBB4 HFM1 TMC2 TNC CSMD1	2.97e-04	53	326	5	EFO_0000203
Disease	lifestyle measurement, alcohol consumption measurement	FSTL5 CSMD2 BACE2 VWF SLC6A1 LRBA CDH17	2.98e-04	115	326	7	EFO_0007878, EFO_0010724
Disease	Brody myopathy (implicated_via_orthology)	ATP2A2 ATP2A3	3.62e-04	3	326	2	DOID:0050692 (implicated_via_orthology)
Disease	congenital myopathy 1A (implicated_via_orthology)	RYR1 RYR3	3.62e-04	3	326	2	DOID:3529 (implicated_via_orthology)
Disease	malignant hyperthermia (implicated_via_orthology)	RYR1 RYR3	3.62e-04	3	326	2	DOID:8545 (implicated_via_orthology)
Disease	facioscapulohumeral muscular dystrophy (implicated_via_orthology)	FAT1 FRG1	3.62e-04	3	326	2	DOID:11727 (implicated_via_orthology)
Disease	small intestine adenocarcinoma (is_implicated_in)	MAP2K1 MAP2K2	3.62e-04	3	326	2	DOID:4906 (is_implicated_in)
Disease	Hamman-Rich syndrome	ABCA3 SFTPA2 SFTPA1	4.44e-04	14	326	3	C0085786
Disease	rostral middle frontal gyrus volume measurement	HSP90AA4P ADGB PLA2R1	4.44e-04	14	326	3	EFO_0010328
Disease	uric acid measurement	ERBB4 HLA-DQB2 ADCYAP1R1 HSF5 ITPK1 NAV1 HFM1 FOXK1 CDC42BPA FAT3 GRB10 PNKD CD160 PACS1 MAP4K5 LRP2 ATP2A2	5.01e-04	610	326	17	EFO_0004761
Disease	high grade glioma (biomarker_via_orthology)	BDKRB2 MET TNC	5.51e-04	15	326	3	DOID:3070 (biomarker_via_orthology)
Disease	Disorder of eye	SLC24A5 CC2D2A CPLANE1 CNGA3 FOXC1 GPR143 BBS7 CDH3 BBS12	6.23e-04	212	326	9	C0015397
Disease	S-warfarin to R-warfarin ratio measurement	CYP2C18 SLC24A4 SLC24A2 ADAMTS5 ARFGEF3 GPR176	6.62e-04	95	326	6	EFO_0803331
Disease	oral squamous cell carcinoma (is_marker_for)	ERBB4 MET PTPN13 PLCG1 KMT2D	6.64e-04	63	326	5	DOID:0050866 (is_marker_for)
Disease	Adenocarcinoma of large intestine	ERBB4 TRRAP MET POLE ROR1 MAP2K1	6.99e-04	96	326	6	C1319315
Disease	cholangiocarcinoma (is_marker_for)	MET HDAC6 SLC4A4 FSCN1 MUC6	7.14e-04	64	326	5	DOID:4947 (is_marker_for)
Disease	Hearing abnormality	APC2 AP1B1	7.20e-04	4	326	2	C4025860
Disease	liver cancer (implicated_via_orthology)	JAK2 POLE	7.20e-04	4	326	2	DOID:3571 (implicated_via_orthology)
Disease	Developmental delay (disorder)	SPART GLRA1 TRAPPC12 ZNF335	7.25e-04	37	326	4	C0424605
Disease	essential hypertension (is_implicated_in)	CYP3A5 NPR2 ATP2A2	9.64e-04	18	326	3	DOID:10825 (is_implicated_in)
Disease	multiple system atrophy	CARD6 XDH PKHD1L1 CDH4	9.77e-04	40	326	4	EFO_1001050
Disease	Nonorganic psychosis	MED12 PICK1 TET1 CDH17 PCNT	1.01e-03	69	326	5	C0349204
Disease	laryngeal squamous cell carcinoma (is_marker_for)	ERBB4 PLCG1 XDH	1.14e-03	19	326	3	DOID:2876 (is_marker_for)
Disease	level of leukocyte immunoglobulin-like receptor subfamily B member 4 in blood serum	SFTPA2 SFTPA1	1.19e-03	5	326	2	OBA_2042200
Disease	fasting blood glucose measurement, glucose tolerance test, fasting blood insulin measurement	MAP4K5 ABCB11	1.19e-03	5	326	2	EFO_0004307, EFO_0004465, EFO_0004466
Disease	Malignant Cystosarcoma Phyllodes	MED12 KMT2D	1.19e-03	5	326	2	C0600066
Disease	Hereditary Hyperexplexia	GLRA1 GLRB	1.19e-03	5	326	2	C1835614
Disease	Endometrial Stromal Sarcoma	NUTM2A NUTM2B	1.19e-03	5	326	2	C0206630
Disease	Hereditary hyperekplexia	GLRA1 GLRB	1.19e-03	5	326	2	cv:C1835614
Disease	Phyllodes Tumor	MED12 KMT2D	1.19e-03	5	326	2	C0010701
Disease	level of prosaposin in blood serum	SFTPA2 SFTPA1	1.19e-03	5	326	2	OBA_2044552
Disease	polybrominated biphenyl measurement, gestational serum measurement, polybrominated diphenyl ether measurement	DLGAP1 MICB	1.19e-03	5	326	2	EFO_0007961, EFO_0007962, EFO_0007964
Disease	Malignant melanoma of iris	CYSLTR2 SF3B1	1.19e-03	5	326	2	C0346373
Disease	Malignant melanoma of choroid	CYSLTR2 SF3B1	1.19e-03	5	326	2	C0346388
Disease	hereditary breast ovarian cancer syndrome (is_implicated_in)	BRCA2 PALB2	1.19e-03	5	326	2	DOID:5683 (is_implicated_in)
Disease	mastiha supplement exposure measurement, blood glutathione peroxidase measurement	SLC24A4 SLC24A2	1.19e-03	5	326	2	EFO_0600067, EFO_0600071
Disease	HMG CoA reductase inhibitor use measurement	HLA-DQB2 BRCA2 UGT2B7 UGT2B10 KPNB1 MIA3 RGS12 MAP4K5	1.26e-03	189	326	8	EFO_0009932
Disease	childhood onset asthma	HLA-DQB2 TNFRSF11A MED24 SFTPA2 MICB SFTPA1 MIA3 WDR36 MED1 NR1D1 EPHB1	1.32e-03	334	326	11	MONDO_0005405
Disease	Osteoarthritis of hip	COMP TNC RUNX2	1.32e-03	20	326	3	C0029410
Disease	esophagus squamous cell carcinoma (is_marker_for)	ERBB4 JAK2 FAT1 RUNX2 KMT2D	1.38e-03	74	326	5	DOID:3748 (is_marker_for)
Disease	fasting blood glucose measurement	PAK6 SLC24A4 SLC24A2 BACE2 FAT3 GRB10 MAP4K5 ABCB11 CSMD1 PROX1	1.43e-03	287	326	10	EFO_0004465
Disease	Idiopathic Pulmonary Fibrosis	ABCA3 SFTPA2 SFTPA1	1.53e-03	21	326	3	C1800706
Disease	serum urea measurement	DLGAP1 DDB2 FBXO22 EPG5 MAP4K5 YY1AP1 PROX1 EPHB1	1.54e-03	195	326	8	EFO_0009795
Disease	Major Depressive Disorder	RELN CMYA5 BDKRB2 MED12 XDH ISG15 CNTNAP2 MAP2K1 PCNT	1.62e-03	243	326	9	C1269683
Disease	pneumonia, COVID-19	LRP1B FAT1 HSP90AA4P CSMD1 CDH4 UNC80	1.63e-03	113	326	6	EFO_0003106, MONDO_0100096
Disease	Disproportionate short stature	ACAN NPR2 COMP RUNX2 PCNT	1.65e-03	77	326	5	C0878659
Disease	X-24947 measurement	ZNF394 UGT2B4 UGT2B7	1.76e-03	22	326	3	EFO_0800910
Disease	essential thrombocythemia (is_implicated_in)	JAK2 VWF	1.77e-03	6	326	2	DOID:2224 (is_implicated_in)
Disease	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1	BACE2 MED12	1.77e-03	6	326	2	C3888239
Disease	Clear cell sarcoma of kidney	NUTM2B NUTM2E	1.77e-03	6	326	2	C0334488
Disease	glucagon measurement, glucose tolerance test	HERC1 MACF1	1.77e-03	6	326	2	EFO_0004307, EFO_0008463
Disease	Hyperekplexia	GLRA1 GLRB	1.77e-03	6	326	2	cv:C0234166
Disease	achondroplasia (implicated_via_orthology)	ACAN NPR2	1.77e-03	6	326	2	DOID:4480 (implicated_via_orthology)
Disease	newborn respiratory distress syndrome (biomarker_via_orthology)	SFTPA2 SFTPA1	1.77e-03	6	326	2	DOID:12716 (biomarker_via_orthology)
Disease	response to gemcitabine, response to antineoplastic agent	PDE4D ALPK3	1.77e-03	6	326	2	GO_0036272, GO_0097327
Disease	cotinine measurement	UGT2B10 CNTNAP2 CDH4	2.01e-03	23	326	3	EFO_0007813
Disease	Nonsyndromic Deafness	ACTG1 MET TNC ROR1 MYO1F	2.06e-03	81	326	5	C3711374
Disease	lung adenocarcinoma (is_implicated_in)	ERBB4 LRP1B JAK2 PTPN13	2.10e-03	49	326	4	DOID:3910 (is_implicated_in)
Disease	vitamin D measurement, COVID-19	UGT2B4 UGT2B7 CEP97 SLC4A4	2.10e-03	49	326	4	EFO_0004631, MONDO_0100096
Disease	Colorectal Carcinoma	MKRN3 ABCA3 FSTL5 APC2 PAK6 DSCAML1 ABCA10 FAT1 TOMM40L PKHD1 ATP11C FLNC ZNF560 POLE LRP2 ABCB11 BPIFB2	2.27e-03	702	326	17	C0009402
Disease	lung squamous cell carcinoma (is_implicated_in)	PTPN13 POLE KMT2D	2.28e-03	24	326	3	DOID:3907 (is_implicated_in)
Disease	alcohol use disorder measurement, alcohol dependence	MICB PKHD1 MAP4K5	2.28e-03	24	326	3	EFO_0009458, MONDO_0007079
Disease	prostate-specific antigen measurement, disease progression measurement	ACAA2 SPHKAP	2.46e-03	7	326	2	EFO_0008336, EFO_0020660
Disease	vanillylmandelate (VMA) measurement	UGT2B4 UGT2B10	2.46e-03	7	326	2	EFO_0800119
Disease	Abnormality of the eye	APC2 MED13	2.46e-03	7	326	2	C4316870

Protein segments in the cluster

Peptide	Gene	Start	Entry
MEGESTSAVLSGFVL	ABRAXAS1	1	Q6UWZ7
SIGSINMSVDIDGTT	ARID3B	491	Q8IVW6
MTDFSVFSNLVTIGG	ERBB4	411	Q15303
VEENMSVQGGLSESA	EPG5	141	Q9HCE0
STNALVIGATVMEGF	BACE2	401	Q9Y5Z0
TASFSADMLNVTLQG	BDKRB2	21	P30411
SGIEEVNMFTNQGTV	BTF3	101	P20290
FDQMLSESVTSIQGG	BBS7	281	Q8IWZ6
NGMIVSSDGILFSSS	CSMD1	2986	Q96PZ7
EVFDGADNTVTMLGS	CSMD2	1851	Q7Z408
EGKTETTMQVGNSQT	CCDC7	421	Q96M83
GIFNFTELIQMESTS	ABCA10	906	Q8WWZ4
ATSGVNESEMAVASG	BRD8	211	Q9H0E9
FSMIVGNATEAAVSS	ADGRF1	311	Q5T601
LENEETMVSSTGKGQ	ADGB	1151	Q8N7X0
DGVGEISSQLMFTIS	CD160	86	O95971
GSVLNTNGEVEMDAS	ASRGL1	66	Q7L266
MDVITGTSFGVNIDS	CYP3A5	181	P20815
ETIIDINGTVMNYSG	ADAMTS5	796	Q9UNA0
VGGSILASLSTFQQM	POTEKP	341	Q9BYX7
IGGSILASLSTFQQM	ACTB	341	P60709
IGGSILASLSTFQQM	ACTG1	341	P63261
VADSNVVLDTTMRGG	COMP	706	P49747
AMEGQSEQEVATSLG	ALPK3	921	Q96L96
GIASFGASITTMEEV	ABCA3	821	Q99758
AAGSQIGMIVNSFTN	ABCB11	871	O95342
GDSEFMNIIANEIGS	AARSD1	321	Q9BTE6
SQQMNLSIGDDSTGS	AKAP11	1721	Q9UKA4
STISQVSEMEVNGQF	DLGAP1	446	O14490
IEAITSSGQMGSFIR	GLE1	656	Q53GS7
NMTQEEFRSLFGSIG	ELAVL4	61	P26378
GTFTRQVGSISMDLQ	AP1B1	736	Q10567
GDTVNTASRMESNGQ	NPR2	981	P20594
DSGLTGSQSEFQKML	CEP83	21	Q9Y592
MLSSRSSGIQVGEQS	AMBRA1	246	Q9C0C7
AEGGMTAVVQREQST	AMBRA1	1156	Q9C0C7
QATDTETTGVEAMGV	ANKRD24	626	Q8TF21
GSQVLLTSSNEMGTV	CLIP4	626	Q8N3C7
SVNGSVMQAFAEAAG	BBS12	436	Q6ZW61
LSMVGQASISGSEDI	CHD7	2366	Q9P2D1
EGVGETMTEEQSQSF	DDRGK1	201	Q96HY6
TESVTQAKAGDGAMT	ARMCX5	46	Q6P1M9
LQSFNEITAMTGDGV	ATP2A3	691	Q93084
QVSEALVDFTGGVTM	CAPN14	196	A8MX76
EQGVLTGMNETSAVI	AP3B1	996	O00203
VSGQLIDSMANSFVG	MAP2K1	211	Q02750
SGQLIDSMANSFVGT	MAP2K2	216	P36507
DMAVSNTIGSNVFDI	SLC24A4	516	Q8NFF2
FGSKNVSGISFTENM	RANBP2	1101	P49792
VSGISFTENMGSSQQ	RANBP2	1106	P49792
LQSATEQMAATVAGS	EDC4	1181	Q6P2E9
IFINSFGSIAETTMD	GLRA3	76	O75311
MEGTSTSSIYQNGDI	JAK2	11	O60674
SMQVLSGVFTDVEAS	PTPN23	441	Q9H3S7
SEGANTMDIGRTVLQ	HACL1	396	Q9UJ83
LRTATANGFQMVTSG	NCLN	176	Q969V3
MTVFTGENSQLQRAG	KCNG3	271	Q8TAE7
SGAAINDTMSDGQTL	ANKFY1	611	Q9P2R3
ENSMTARNTTVSGAG	DSG2	1066	Q14126
ASQQVSTMGDRGTSN	OR9K2	16	Q8NGE7
GFTSLQLVTQMTSED	EPHB1	936	P54762
STFSDMNIILAGGQV	FBXO22	241	Q8NEZ5
VIFMNSTDLDTGFNG	FAT1	736	Q14517
GSQGMEETSQLTLSD	FHDC1	686	Q9C0D6
GNTATLTISGTQAMD	IGLV3-1	86	P01715
TSMGIAEGTASLFVD	MUC6	546	Q6W4X9
VGGSILASLSTFQQM	POTEF	1041	A5A3E0
MSGENNSSVTEFILA	OR8G1	1	Q15617
SGGINSTVQTSLAMR	OR13C4	151	Q8NGS5
MDAGVTESGLNVTLT	PCBP1	1	Q15365
MEFLQGGALTDIVSQ	PAK6	481	Q9NQU5
TVGNIVTGTDEQTQM	KPNA7	306	A9QM74
VTGTDEQTQMAIDAG	KPNA7	311	A9QM74
QTDGYAGVNVTDLTM	MICAL3	531	Q7RTP6
QGMVSDASANEILGS	MDN1	2706	Q9NU22
GLQSTFLAMDTEEGV	NRBP2	51	Q9NSY0
QGQSTAMAATGDVAL	ITPK1	321	Q13572
GSKMATLSSVNGNEI	LRP1B	221	Q9NZR2
MSDTSESGAGLTRFQ	MAGED2	1	Q9UNF1
GVSSLNSGQIEVIMD	MAN2A1	941	Q16706
NVVSTGSGMAEASLE	GPR176	346	Q14439
DVSLVEGSNDIMGST	MEPE	331	Q9NQ76
GTMATLTISGAQVED	IGLV3-10	86	A0A075B6K4
MLLVGTGFTQQTEEQ	LRRK1	956	Q38SD2
FETSAQTGEGINEMF	DNAJC27	161	Q9NZQ0
MTESDTASVNENGLV	FXR1	521	P51114
NQGISELNASSVGMA	PHKA1	191	P46020
NFGAITLNSMDATSE	ASL	221	P04424
AGNEFQVSLSSSMSV	ISG15	11	P05161
GGDDEVMSSTLQQFS	APPL1	76	Q9UKG1
TQVADVLQFSMETGG	EXD1	181	Q8NHP7
DNQTTLQTLADMGGD	HERC1	3401	Q15751
NSGNIFVVSLSVADM	GPR50	61	Q13585
IELSMQGSSGNTSQD	ATXN3L	251	Q9H3M9
LQTGQEIMELDTSGF	CPSF1	586	Q10570
AQSESAQSKMLSGIG	HLA-DQB2	221	P05538
SSGNMSVLSDSAGIV	NHSL1	301	Q5SYE7
SSVQEAGSMAGVLIA	PLXNA1	161	Q9UIW2
FFQINGSTGEMSTVQ	FAT2	2321	Q9NYQ8
ICLTFTDNGNGMTSD	MORC3	61	Q14149
NGESMSVGLLSQTYL	MORC3	121	Q14149
VEGGSSSVFSMFDQT	MYLPF	11	Q96A32
TNGLSAEMTGTNELS	MUC19	5911	Q7Z5P9
EMSRSGNQVSEFISN	PDE4D	321	Q08499
VSYGQGSIQSMVSSD	PEAK1	326	Q9H792
NMKGNDISSGTVLSD	PEBP1	91	P30086
GEDLQFDQLISSMSS	FRYL	51	O94915
VNQMLSDTDGSSAVF	FRYL	2691	O94915
ITGDDSMRTSQLNVG	FLNC	1946	Q14315
VSSAEMSQGTNVGKA	FYB1	661	O15117
ATLQGGEMTIQTTQA	NRF1	361	Q16656
GSTSVQTAMESELGE	DEPDC1	541	Q5TB30
DTIMELVGFSNESLG	NOD1	161	Q9Y239
VAAAITQEGMSAVAG	MACF1	936	O94854
VVSSVDSAQASDMGG	LRBA	1751	P50851
GGMFDTVQRSTQQTT	MED12	1541	Q93074
ISGTVDMQSNNELFT	MED12	1566	Q93074
GEVANEVTMGVAASS	GARIN5A	141	Q6IPT2
IFINSFGSIQETTMD	GLRB	86	P48167
MTQFLEQGEATLSVA	FAHD2A	66	Q96GK7
YDGSGQIAMTTNLLS	LRP2	2621	P98164
NLMVLSQDGSVQSGF	MICB	31	Q29980
ADSMGISFDVIQQAS	POLE	1751	Q07864
IAAFQTKSGTASEMG	HEG1	221	Q9ULI3
TGDLTMDTDLTAANG	HSPA12A	146	O43301
GMGEQLTETFALDTN	PGGHG	71	Q32M88
EFMVTVNSGLISVGS	OR4F15	196	Q8NGB8
ASSRMVVTGDNVGNV	DDB2	211	Q92466
GGFQDSEQETLSMIA	PCNT	3161	O95613
FQETAGAMLASQETS	EXOC7	516	Q9UPT5
GDSNSLDLSDMGVVS	ADCYAP1R1	101	P41586
AGSETGNFLVMEELQ	PCDHB12	26	Q9Y5F1
PFFEGMSQSSSQTEI	PACS1	401	Q6VY07
DQQSVTFGTKSRVGM	ALDH18A1	291	P54886
MVDVSGQFSGTVDSS	ACAN	1871	P16112
LDDVLIGMNDSSQTG	RELN	1591	P78509
QVMVDGVTDSVIGFN	FSTL5	676	Q8N475
LSGSTSMTFLNRGQI	HMCN1	1961	Q96RW7
TANNAFSASEIGEGM	HFM1	221	A2PYH4
IASNVTETMGINGSA	NPC1	1061	O15118
SGTLSDQQVEVMTFA	PALB2	981	Q86YC2
FAEVQGMQEALLGTT	PALB2	1016	Q86YC2
VGGSILASLSTFQQM	POTEE	1041	Q6S8J3
TTVSGLQMALDVYNG	ACP3	291	P15309
QIMSSAFQASLEGGL	POMT1	296	Q9Y6A1
AGSYIMGSINASVQT	OR5AK2	146	Q8NH90
ASQSAGMTVTDQAFV	GYG2	26	O15488
GMTVTDQAFVTLATN	GYG2	31	O15488
MTTLDSNNNTGGVIT	NR1D1	1	P20393
AAGRVGSDMTSQQEF	PEX19	111	P40855
MSSEDQASGGIVLQL	C1QTNF9	281	P0C862
QEQGSSFQMSEGSEA	FAM189A2	206	Q15884
TNFGEISGTIAIEMD	FRG1	51	Q14331
IMASNGSLISSGSQD	FRMD4B	401	Q9Y2L6
AGMTLTNLTFGDVAN	APC2	466	O95996
QSFDEITAMTGDGVN	ATP2A2	691	P16615
MSSNRSAAGVTVFEG	KLHL18	416	O94889
AVLLMDTQGTFDSQS	ATL1	141	Q8WXF7
RIQVSSGENMAGTAE	CARD6	666	Q9BX69
EADGSNQLTLMTSGK	CC2D2A	786	Q9P2K1
MDVITGTLFGVNLDS	CYP3A43	181	Q9HB55
MTANGTAEAVQIQFG	FSCN1	1	Q16658
NNIEMTTGTFVEEIT	BRCA2	1296	P51587
VSSEELGLTEQAMGT	CPLANE1	2861	Q9H799
MTQFLEQGEATLSVA	FAHD2B	66	Q6P2I3
VTNTFGSAEATGILM	DSCAML1	296	Q8TD84
QGFSVDNIMTSLRGS	FOXC1	306	Q12948
EGSESSIMGNSIDTV	CEP97	726	Q8IW35
GTDGTQVAMVQFTDD	COL14A1	1066	Q05707
ESSAIGGQLMASAAT	ARFGEF3	826	Q5TH69
GDSEEMNINSVVTSA	CMYA5	2296	Q8N3K9
VSQVGGQTSDEALSM	GPR143	356	P51810
VGVVLTTGQDSQSMR	GUCY2F	216	P51841
MVDYTTLSGASQING	CDON	1016	Q4KMG0
GIGNADITEMQTISF	COL6A3	1166	P12111
NITATDGLFVTQAMV	FAT3	3001	Q8TDW7
VGNMTGTTEINSDRS	GON4L	941	Q3T8J9
ASGIQMSFQSTAGVT	CDH4	481	P55283
QGSVDLSMGLSSFIS	FOXK1	131	P85037
MVQIQTGLSGQNDTS	CD52	16	P31358
SGGVQEDALMAVSTL	KPNB1	621	Q14974
NIFGSSQMGATIVDA	MAN1A2	216	O60476
LQDQSSISGSGIMAD	ITIH6	231	Q6UXX5
SLSMFGQSISGQIDA	ITGA4	426	P13612
LLVGESATTFAQSMG	AGA	126	P20933
AQSMGFINEDLSTTA	AGA	136	P20933
GSTALMVALDAGQSE	KANK2	806	Q63ZY3
MTNLGTGFSSQNEIE	KHDC4	486	Q7Z7F0
SVSENSLVAMDFSGQ	GRB10	426	Q13322
MSDVGTFVVQVTATD	CDH6	171	P55285
KMSQIDISSGSGLND	CNTNAP2	441	Q9UHC6
SLIATVTDMFGAGTE	CYP2C18	286	P33260
GSGVTMEFTIQDILD	EXOC1	871	Q9NV70
IVATGQVGDSADMSA	EML5	1431	Q05BV3
QATGVSFTMDQDTTL	DNAH9	1391	Q9NYC9
VLQAGADISMIGQFS	HSP90AA4P	61	Q58FG1
GGATLAQTTSEAAME	HDAC6	986	Q9UBN7
VSSGSGQNDLEKMTS	GMPR	101	P36959
TTTEFEMAGNRSQNI	DNAJC9-AS1	101	A6NH13
LVNFLEDGSMSVTGI	GEMIN6	46	Q8WXD5
ISVKDMGGQSENSFS	CDH17	211	Q12864
MSSTVQGSNIFERTE	SDC4	131	P31431
GSFMDTDQRKTVSQG	SDK1	191	Q7Z5N4
GISTMEESVTLDNGG	SDK1	2046	Q7Z5N4
FTLNGEVLMSDSGSE	RYR1	1161	P21817
QVADMSGDGLTATAS	CDH15	231	P55291
SNVQLADTVMFTIGA	IPO13	501	O94829
LTIQATDMDGDGSTT	CDH3	296	P22223
MFGKTLSGTNSISQE	MAP3K19	941	Q56UN5
LGMNASVTIEGTSAV	MED1	251	Q15648
GISKLMSENTEGSAQ	MAP4K5	451	Q9Y4K4
TLLAVSGMNGDNTDS	NR2E1	241	Q9Y466
GVSTQGMTLEEVNRA	PTPN13	1936	Q12923
SFSSLMQIEEAGQTT	PRR14L	511	Q5THK1
MVDVSGTGTLSQSYQ	PCDHB3	736	Q9Y5E6
QSEGSEFLLLGMSES	OR1D2	6	P34982
TGLVDSVVQTAFAMQ	OR13C8	151	Q8NGS7
SGAGASNVFVQMRTE	NUTM2A	196	Q8IVF1
SGAGASNVFVQMRTE	NUTM2B	196	A6NNL0
SGAGASNVFVQMRTE	NUTM2E	196	B1AL46
INSASFSQGLELMSG	NAV1	851	Q8NEY1
METGNVANLISIFGS	IER5	261	Q5VY09
TIANLGTSEGRFMQV	MET	451	P08581
GTVVTVMAGNDENYS	RUNX2	151	Q13950
VLTGTEQGMTETFGT	RTCB	411	Q9Y3I0
SGSQMSLSGDAEAVQ	SYTL1	251	Q8IYJ3
SSSELVGVYTGQMSN	TAF5L	551	O75529
GSDIMSFVVGTEQAV	HSF5	436	Q4G112
TFGQDFTLGQVEVSM	SYT12	146	Q8IV01
EDNSIQTMITFDQGG	SORT1	421	Q99523
NGNSSATSSLGIMDL	SPHKAP	1546	Q2M3C7
MGITSENVAERFGIS	ACAA1	181	P09110
IQDMVAGENTSEAGS	TIGD6	436	Q17RP2
GRTFEGNAETMLSSL	PNKD	261	Q8N490
MATNGSKVADGQIST	SLC6A1	1	P30531
NLLTDSGGFQMVSLV	QTRT1	101	Q9BXR0
SGGFQMVSLVSLSEV	QTRT1	106	Q9BXR0
GEMTNSSIATENFPA	PRUNE2	2006	Q8WUY3
LELMSTGGESSVQEN	PPP4R4	461	Q6NUP7
TGSLQGDSMTETVAE	SYNM	626	O15061
AMQGTEVGQTDQTDS	MIA3	696	Q5JRA6
GDMAVSSSVGSNIFD	SLC24A2	561	Q9UI40
GASVSINVNTSLEDM	SLC26A6	606	Q9BXS9
TQSSEFGASQVVSME	NEXMIF	911	Q5QGS0
QENTSVEVSGFRMTG	PKDREJ	921	Q9NTG1
IFINSFGSIAETTMD	GLRA1	71	P23415
QVTQTMLSFLAATGD	NBEAL2	1111	Q6ZNJ1
EVTQGMSAETAVTFL	NBEA	1421	Q8NFP9
LDTFGNVQMASSTDQ	PROX1	421	Q92786
SSSAEAQGLMTAVGQ	SPATA31A7	1201	Q8IWB4
AATVTGQMFLESQEL	ERCC5	761	P28715
EGTMNLTGETQSLVE	MED24	251	O75448
VAGTEMSQSDSGVDL	PRRC2A	1641	P48634
GDVTVTNDGATILSM	CCT5	66	P48643
VGGSILASLSTFQQM	POTEI	1041	P0CG38
QISGAANIDIFIGMS	PKHD1	1676	P08F94
ALQGVTLQQMDFGST	TSC22D1	511	Q15714
IMTVGEKVFSSNGQS	SFTPA2	131	Q8IWL1
MLDSGQSEVFVSNIL	STX4	176	Q12846
ATMAQGLGLETDATE	ESRP2	181	Q9H6T0
FGQESVTSVTELMVQ	MED13	646	Q9UHV7
SQMFLDQLSAGGSTS	PIAS1	586	O75925
MGTGNDTTVVEFTLL	OR5P3	1	Q8WZ94
LMEDGTVQSSVAVGT	CDC42BPA	226	Q5VT25
QNLTMTVFQGDGTAS	SIGLEC12	366	Q96PQ1
NSSMVLGARDTGSEV	SETD1A	516	O15047
QMQGGTLLSITDETE	PLA2R1	261	Q13018
IMTVGEKVFSSNGQS	SFTPA1	131	Q8IWL2
MGTTATETLAVAGNI	SLC28A2	296	O43868
TETLAVAGNIFVGMT	SLC28A2	301	O43868
TILDQQETLGMSGSV	TET1	411	Q8NFU7
NSVDGMELTSQGAGT	TLK2	626	Q86UE8
EGSMATVGLSQQLFD	BPIFB2	251	Q8N4F0
VQRAFEGTTLAMTNG	APOL5	276	Q9BWW9
IFATIVGNVGSMISN	CNGA3	391	Q16281
SISVSEMEPNGTFSN	CYSLTR2	11	Q9NS75
IMLLDSGSEQNGSVT	CYSLTR2	171	Q9NS75
SIGDGANDVSMILES	ATP11C	816	Q8NB49
LVGAGMTFIVQSSSV	SLC34A2	421	O95436
VDSVIMGNVLQSSSD	ACAA2	51	P42765
GEIENQITAAFTMIG	ROR1	196	Q01973
SQMFSAIAAVTGQGQ	SUPT6H	1561	Q7KZ85
SSSAEAQGLMTAVGQ	SPATA31A3	1201	Q5VYP0
SASEGSNMIGTEETN	VPS50	356	Q96JG6
DQESMNTGTLASLQG	USP17L3	496	A6NCW0
TLDRTGSMLQNGVSD	SPATS2	171	Q86XZ4
GSMLQNGVSDFETKS	SPATS2	176	Q86XZ4
TGFQQSSLNMDEVSS	ZXDB	686	P98169
SSISGVDMAGLQTSF	TMF1	936	P82094
DGAMVVAASSVQGFS	SPART	536	Q8N0X7
LDGTSSQGMVTFEDT	ZNF394	146	Q53GI3
SESVAGTGMIGENEQ	ZNF143	196	P52747
VMSSGGQALRSEEFS	TTBK1	941	Q5TCY1
TGQNVIEVMSAASFL	ZBTB8A	91	Q96BR9
STAQNVEGIIVSAMF	UNC80	891	Q8N2C7
MITSLEGLGTDNVFS	WDFY3	981	Q8IZQ1
DQESMNTGTLASLQG	USP17L4	496	A6NCW7
FFGLVTMQTNDDGSL	RGS12	311	O14924
NGANDFMLRDGTVTT	VWF	2091	P04275
QSSETERKQMAVGSG	MKRN3	226	Q13064
MDGEGTLFQTESPQS	PBXIP1	56	Q96AQ6
SSSAEAQGLMTAVGQ	SPATA31A1	1201	Q5TZJ5
SSSAEAQGLMTAVGQ	SPATA31A5	1201	Q5VU36
EQGLAEDGGMSSVTQ	TRAPPC12	516	Q8WVT3
SSFQGELMDGDQTSR	RNF34	191	Q969K3
TTANGTISFTEMVQD	SLC26A11	291	Q86WA9
ENGVVVFSLGSMVSN	UGT2B4	301	P06133
SQIGRMNLGTDASTF	RYR3	1196	Q15413
QEQTTEDSVMLNGFG	SF3B1	901	O75533
EDSVMLNGFGTVVNA	SF3B1	906	O75533
LTVTENIFSSMGDAG	TLN1	806	Q9Y490
ESTKNLVESSMVNGG	SPIRE1	416	Q08AE8
LVESSMVNGGLTSQT	SPIRE1	421	Q08AE8
QYSNTGDMILVVSGS	WDR70	236	Q9NW82
STGNLSSSFMEEIQG	TRAF6	41	Q9Y4K3
NLTGVGSFMQSQAAV	SUPT20H	686	Q8NEM7
GSFMQSQAAVLSQLG	SUPT20H	691	Q8NEM7
QAMLNGDTTSGLYTI	TNC	1986	P24821
SLGLSQDVAGTTFMA	SLC24A5	101	Q71RS6
GQTVMLGNSEFDSLV	PLCG1	721	P19174
SNITVMFLGSNDGTV	SEMA6C	436	Q9H3T2
GEAGEMELFVSTQNT	XDH	756	P47989
ISVLRGMDGSTNETA	RRP15	211	Q9Y3B9
SSIGGMVSSQELAED	SPTA1	1306	P02549
DQESMNTGTLASLQG	USP17L1	496	Q7RTZ2
SNGTTGQMQLSELQE	PKHD1L1	4006	Q86WI1
DNMGASSITQETSLG	PIGR	696	P01833
MGTTATETLSVAGNI	SLC28A1	301	O00337
QGQAISVVGSLSSMS	SYMPK	496	Q92797
REVGNMTGTTEINSD	YY1AP1	396	Q9H869
VNGVSMENATSAFAI	TJP3	61	O95049
ATGFQQSSLNMDEVS	ZXDA	681	P98168
FLQTVTGSGMSEVIA	XPOT	801	O43592
TVVGDMDSSGSLNAQ	TOMM40L	96	Q969M1
METATQREGNSGGKT	ZNF230	66	Q9UIE0
TIMFATAGTLNAENS	TLN2	1996	Q9Y4G6
MEEFVQSSGENGVVV	UGT2B10	291	P36537
DQESMNTGTLASLQG	USP17L7	496	P0C7H9
DQESMNTGTLASLQG	USP17L8	496	P0C7I0
DNMQGVLESFLGTAV	SLC4A4	496	Q9Y6R1
LVQAMVQESSGGFSE	ZNF407	2151	Q9C0G0
REESMGEQSSTAGLN	TEX15	56	Q9BXT5
VIRSMASNTQGSTGE	TMC2	356	Q8TDI7
SFTTMQEQTFGGEEE	VEZT	751	Q9HBM0
GNSGDKIQTEMETVS	ZNF224	76	Q9NZL3
ENGVVVFSLGSMVSN	UGT2B7	301	P16662
MILLSFVSDSNVGTG	ZNF623	1	O75123
AMAQAQGLFGTDETV	ZNF335	1306	Q9H4Z2
VENMSSGTADALGLS	PICK1	126	Q9NRD5
ALMQVAGQEGTFSLV	ZNF438	81	Q7Z4V0
MAFVATQGATVVDQT	TRRAP	1	Q9Y4A5
GLENVSNVSTMFSSA	TRRAP	3381	Q9Y4A5
QTTARNTFQEEGSGM	SAMD4A	311	Q9UPU9
GAVQVMATQDGANFT	WNT2B	271	Q93097
RSQKGSSGDQEMTAT	ZKSCAN8	196	Q15776
TSNGIQMDLVTFDSV	ZNF560	101	Q96MR9
DQESMNTGTLASLRG	USP17L10	496	C9JJH3
STFISSGQVMNFKGD	TNFRSF11A	531	Q9Y6Q6
IGLSSGTVDVYNMQS	WDR36	511	Q8NI36
VEEQGPNSSATFMVS	GEMIN4	591	P57678
STEVYETQGGALMNV	KMT2D	5066	O14686
LAAVDSGVMGISSDQ	LEG1	141	Q6P5S2
GLTQSDVSSFMDSNI	NLRP14	451	Q86W24
SDFGETLSAMQVIGI	MYO1F	251	O00160